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A NOVEL SWITCH-LIKE FUNCTION OF DELTA-CATENIN IN
DENDRITE DEVELOPMENT

Ryan Baumert, Ph.D.
Advisory Professor: Pierre D. McCrea, Ph.D.

The formation of neuronal networks in the brain is tightly regulated, and dependent on the
morphology of dendrites, the branch-like signal-receiving structures extending from neurons.
Disruptions in dendrite development, or dendritogenesis, can lead to the atypical neuronal
connectivity associated with multiple neurodevelopmental diseases. My research addresses
molecular processes that underlie dendritogenesis via analysis of a pair of novel interactions
involving the protein delta-catenin.
In neurons, delta-catenin localizes to dendrites and synapses, where it functions in their
development and maintenance. Structurally, delta-catenin possesses a central Armadillo domain
and a C-terminal PDZ-binding motif. This motif associates with PDZ domain-containing proteins, and
is crucial for the neuronal functions of delta-catenin. My research has revealed two novel
interactions between delta-catenin and the PDZ domain-containing proteins Magi1 and Pdlim5.
Through the use of cell-lines and primary neuronal cultures, I have begun to reveal the
functions of these proteins in dendrite development. My findings suggest that delta-catenin is
required for the extension of dendrites, and induces dendritic branching during neuronal
development. My work has also shown that Magi1 promotes dendrite extension, but not dendritic
branching. Conversely, Pdlim5 appears to function in restricting dendrite growth, while
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simultaneously promoting dendritic branching. This presented me with the perplexing thought that
either of these two proteins, with seemingly opposing dendritic roles, can each bind the PDZ-binding
motif of delta-catenin.
Further analysis of these proteins revealed a potential “phospho-switch” mechanism in the
function of delta-catenin. Specifically, I found a pair of critical serine residues within delta-catenin
(S1245 and S1242), that enable it to bind Magi1 (when unphosphorylated) or Pdlim5 (when
phosphorylated). Expressing delta-catenin mutants, which mimic the unphosphorylated versus
phosphorylated state, shifted its function between promoting dendrite elongation or branching,
respectively. Looking upstream of delta-catenin phosphorylation, my findings implicate the
glutamate receptor mGluR5, which has extensive roles in dendrite development, in this pathway.
Lastly, my investigation suggested that Rho-family GTPases lie downstream of these delta-catenin
complexes, thereby linking them to cytoskeletal regulators with established roles in dendritogenesis.
Overall, my research furthers our understanding of the mechanisms underlying dendrite
development, and may help provide insight into the progression of several neurodevelopmental
disorders.
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Chapter I

Introduction

1

Dendrites and their functions in the nervous system:
Dendrites are the branch-like structures that extend out from most neurons and are responsible for
receiving most of the signals a cell receives from the neurons it is associated with (Figure 1). These
signals are transmitted across specialized cell-cell junctions known as synapses, which typically form
between a dendrite and an axon terminal, the second specialized branch-like structure of a neuron.
Because the vast majority of these synapses form on dendrites, the formation of a functional
network of neurons in the brain is highly dependent on the proper development of dendrites, a
process known as dendritogenesis.

Dendritogenesis is a tightly regulated process that relies on the organized branching and elongation
of neurites, or the protrusions from a neuron’s cell body (soma) that ultimately develop into
dendrites. Abnormal dendrite development can lead to atypical synaptic connectivity in the brain,
and has been linked to multiple neurodevelopmental and cognitive disorders. Specifically, in Down’s
syndrome patients, infants appear to possess abnormally long and over-branched dendrites, with
patients over the age of 2 years exhibiting severely shortened and under-branched dendrites when
compared to controls (Becker, Armstrong, and Chan 1986). In contrast, Rhett Syndrome patients
show reductions in dendrite branching throughout life, with severe defects in dendrite morphology
being first apparent very early in brain development (Armstrong et al. 1995). In Autism Spectrum
Disorder, which is often associated with other mental disorders, reduced dendritic branching in the
CA1 and CA4 regions of the hippocampus have been observed in patients, and several Autismrelated genes and genetic models have also been shown to result in neurons with restricted
dendritic arbors (Kulkarni and Firestein 2012; Raymond, Bauman, and Kemper 1995). Reduced
dendritic arbor size (lack of both elongation and branching) has also been observed in the brains of
schizophrenia patients, while neuronal populations and axon morphology appear to be
2

Figure 1. Simplified diagram of a neuron.

Dendrites are the branch-like structures that extend out from the cell body (Soma) of a neuron. They
are largely responsible for the receiving of synaptic input from the presynaptic axons of other
neurons. Dendrites extend and branch in a highly orchestrated manner in order to establish
adequate coverage and connectivity within their larger neuronal network.

3

normal (Broadbelt, Byne, and Jones 2002). Additionally, chronic stress, anxiety, and depression have
also been linked to dendrite atrophy and reductions in dendritic arbor size in the hippocampus (in
both humans and mouse models), both of which are believed to be related to elevated levels of
stress-response hormones, such as corticosterone (Radley et al. 2004; Kulkarni and Firestein 2012;
Soetanto et al. 2010). Lastly, reductions in dendritic arbor size have been observed during the
progression of Alzheimer’s disease, although these changes in dendrite morphology are related to
the deterioration of dendritic structures, rather than defects in their development (Avila et al. 2017).
Nevertheless, the prevalence of disrupted dendrite morphologies in these cognitive disorders
strongly suggests a key role of dendrites in the normal functioning of the central nervous system,
and calls for a need to establish a better understanding of the development and function of these
neuronal structures.

It is also worth noting that all of the above studies are in reference specifically to dendrite
morphology. Many of those mentioned, and numerous additional cognitive disorders, have been
strongly linked to the abnormal development and organization of dendritic spines, which are the
dendritic structures that directly compose synapses, and whose development may be dependent on
some of the same pathways underlying dendrite development (Kulkarni and Firestein 2012).
Nevertheless, developing a better understanding of the pathways underlying dendrite formation
may provide insight into the mechanisms responsible for the atypical dendrite morphology
associated with the above neurodevelopmental and cognitive disorders, and in turn, assist in the
identification and production of new therapeutic options.

4

Dendrite morphology and specification:
Dendrite and axon morphological differences:
During neuronal development, neurons begin extending protrusions out from the cell body, or
soma. These protrusions, known as neurites, are the structures that eventually become specialized
branch-like structures known as dendrites, with typically a single neurite developing into the axon of
a neuron. Despite their similar origins, dendrites and axons serve vastly different roles in the
nervous system, with dendrites typically receiving signals from other cells and axons typically
transmitting signals to other cells. While this work is focused solely on dendrite morphology, it is
worth noting the functional, structural, and developmental differences between axons and
dendrites in order to provide a more detailed description of dendrite development. The
specification of a single axon from the neurites of a neuron is a key aspect of neuronal polarization
and development. During development, a single neurite is often observed to grow much more
rapidly than its counterparts. This elongated neurite will eventually become the axon, and while the
precise mechanism by which this future axon is determined remains unknown, there are several
observed factors that contribute to the dendrite-axon specification process that will be covered
later in this section.

Perhaps the most notable difference between axons and dendrites is the presence of dendritic
spines along the lengths of mature dendrites. First described over 100 years ago by Santiago Ramon
y Cajal, these relatively short protrusions act as the receiving end of most excitatory synapses and
interface with the pre-synaptic axon to form a synapse (Ramón Y Cajal 1888, 1899). While dendritic
spines exist in a variety of shapes, the most classical representation is a short “mushroom-shaped”
protrusion with a thin neck and a bulbous head, which contains the post-synaptic density (Ethell and
Pasquale 2005). The post-synaptic density comprises a highly-specialized densely packed region of
5

ion channels and receptors associated with synaptic signal transmission, as well as scaffold proteins
which link the density to the actin cytoskeleton of the dendritic spine (Hering and Sheng 2001). This
post-synaptic density is the primary point of signal reception on dendrites from pre-synaptic axons
and undergoes constant remodeling throughout the life of a neuron as synaptic connections
strengthen and weaken in response to changes in neuronal activity, and often occurs in the form of
redistribution of neurotransmitter receptor and ion channel pools (Hering and Sheng 2001).
Remodeling of the broader spine morphology occurs, in part, due to dynamic regulation of the
cytoskeleton of dendritic spines (Colgan and Yasuda 2014). While the dendrite cytoskeleton is
composed of both microtubules and actin filaments, dendritic spines mostly lack microtubules, and
are largely supported by a highly dynamic actin network (Hering and Sheng 2001). This actin
network acts as the primary supporting structure responsible for dendritic spine development and
remodeling throughout the life of the neuron, and forms unique structural networks within the
spine (AY Nakayama, Harms, and Luo 2000; Hering and Sheng 2001). Several groups have found that
actin assembles into longitudinal bundles in the spine neck and a meshwork in the spine head, with
the dynamics of both structures contributing to the remodeling of dendritic spine morphology
(Korobova and Svitkina 2010; Ethell and Pasquale 2005). Dendritic spine actin dynamics, and
subsequently dendritic spine morphology, is largely regulated by Rho-family GTPases and several
other actin-associated proteins during both synaptic development and remodeling (Govek, Newey,
and Van Aelst 2005; AY Nakayama, Harms, and Luo 2000). These actin regulatory proteins have
diverse roles and upstream signaling components in the context of synapse development and
remodeling, and are each crucial for the formation of functional dendritic spines.

The cytoskeletal regulatory roles of Rho-family GTPases, particularly RhoA, Rac1, and Cdc42, are
perhaps the best-characterized actin regulators in the context of dendrite spines (AY Nakayama,
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Harms, and Luo 2000; Luo 2000). All three of these molecules are expressed nearly ubiquitously in
neurons and, interestingly, have distinct roles in the development and remodeling of dendritic
spines and the actin network that supports them (Olenik et al. 1997; Ethell and Pasquale 2005).
Studies involving the expression of constitutively active Rac1 revealed the formation of increased
densities of spines along dendrites, both in vivo and in vitro (Luo et al. 1996; Tashiro, Minden, and
Yuste 2000). Interestingly, these dendritic spines are long and thin when compared to normal
spines, and generally lack the ability to form functional synapses in vitro, suggesting that Rac1 may
function primarily in the initial formation of dendritic spine protrusions, but is downregulated during
later stages of spine development (Govek, Newey, and Van Aelst 2005; AY Nakayama, Harms, and
Luo 2000; Tashiro, Minden, and Yuste 2000; H. Zhang et al. 2003). In agreement with these findings,
expression of a dominant negative Rac1 in hippocampal neurons results in a reduced number of
dendritic spines and synapses, further supporting the role of Rac1 in spine formation (AY Nakayama,
Harms, and Luo 2000; Penzes et al. 2003; H. Zhang et al. 2003). In contrast to the function of Rac1,
RhoA is believed to function in dendritic spine retraction, as expression of a constitutively active
RhoA has been shown to reduce the overall number of dendritic spines in hippocampal neurons.
Interestingly, when RhoA activity was inhibited in these studies, neurons developed an increased
number of dendritic spines, with long and thing morphologies resembling that of constitutively Rac1
expression (Govek, Newey, and Van Aelst 2005; Tashiro, Minden, and Yuste 2000). The third Rhofamily GTPase implicated in dendritic spine development, Cdc42, is not as well understood by
researchers in this context as its relatives. Nevertheless, expression of a dominant-negative Cdc42 in
hippocampal neurons results in decreased dendritic spine densities along dendrites, suggesting that
this protein does in fact play a role in spine development (Irie and Yamaguchi 2002). Taken together,
these findings reveal key roles of the Rho-family GTPases in dendritic spine development, likely
through their regulation of actin dynamics.
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While the development and remodeling of dendritic spines have been heavily studied, the
mechanism of their initial formation remains highly debated, as numerous mechanisms have been
observed. One such mechanism is via filopodial precursor structures, which project from dendrites
and have been linked to spine formation, as these structures have been found to interact with
nearby axon terminals (Ziv and Smith 1996). Additionally, it has been shown that glutamate signaling
induces the formation of these dendritic protrusions, which supports the theory that pre-synaptic
signaling contributes to filopodia development, though the ultimate fate of these glutamate-induced
formations remains to be determined (Portera-Cailliau, Pan, and Yuste 2003). A second proposed
mechanism of dendritic spine formation is their formation around synapses along the dendrite shaft.
This theory is based on the observation that relatively few synapses actually form of filopodia, with
most forming on the dendrite shaft prior to spine formation (Harris, Jensen, and Tsao 1992).
Further, the relative proportion of shaft synapses decreases as dendritic spine-based synapses begin
to arise (Dailey and Smith 1996). In addition to these examples of pre-synaptic signaling events
inducing spine formation, the development of dendritic spines prior to any pre-synaptic contacts has
also been observed in certain contexts, signifying that the development of dendritic spines can occur
through pathways independent of cues from nearby axons (Sotelo 1990; Takács et al. 1997). The
evidence supporting each of these theories of spine formation suggests that there are numerous
factors that can contribute to the formation and further development of these structures. While
beyond the scope of this work, it will be interesting to learn how the mechanisms of dendrite
development revealed here interplay with the pathways underlying dendritic spine development. In
summation, dendritic spine development is a complex and tightly regulated process with remodeling
of these structures occurring throughout the life of a neuron. Further, dendritic spines represent a
morphological feature unique to dendrites, and contribute to the distinct roles of dendrites in the
transmission of neuronal signals.
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In addition to the presence of dendritic spines, dendrites exhibit several key differences from their
axon counterparts that allow the two structures to fulfill distinct roles in the nervous system. The
two most iconic markers of these structures, MAP2 (dendrites) and Tau (axons), are both
microtubule-associated proteins that have functions in neuronal polarity (Dehmelt and Halpain
2004). The differential localization of MAP2 and Tau to dendrites and axons, respectively, is believed
to stem from a combination of interaction stability and mRNA transport (Hirokawa et al. 1996; Kanai
and Hirokawa 1995; Garner, Tucker, and Matus 1988). Specifically, it has been found that Tau
becomes localized to axons through the destabilization of its microtubule association via
phosphorylation events that occur in dendrites, but not in axons (Utton et al. 2005; Wagner et al.
1996; Kanai and Hirokawa 1995). Localization of MAP2 to dendrites has been found to be the result
of MAP2 mRNA transport to the dendrites, as well as the N-terminal projection domain of MAP2
preventing it from entering the axon (Kanai and Hirokawa 1995; Garner, Tucker, and Matus 1988).
Additionally, while recent studies have found that axons and dendrites share many similarities at the
cytoskeletal level, there do exist differences in cytoskeleton organization between these two types
of neuronal protrusions (Konietzny, Bär, and Mikhaylova 2017; Coles and Bradke 2015). Namely, the
polarity of microtubules (plus versus minus end) is highly diverse in dendrites, while in axons,
microtubules largely orient with their plus ends facing away from the cell body (Baas et al. 1988).
These differences in microtubule polarity are associated with the different cargo transport functions
of axons and dendrites, acting as one of the many features that generate the vastly different roles of
these structures in the nervous system (Kapitein et al. 2010). Additionally, until recently, another
key difference between the cytoskeletal organization of axons and dendrites was believed to be the
presence of highly organized actin ”rings” in axons, also known as the membrane-associated
periodic skeleton, which function to maintain microtubule organization in these protrusions (K. Xu,
Zhong, and Zhuang 2013). However, recent findings suggest that these actin rings are also present in
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some dendrites, although they are much less prevalent here. At 5 days in vitro (DIV), virtually all
axons in the hippocampus exhibit actin rings, while only around 25% of dendrites have a detectable
similar actin organization (D’Este et al. 2015). Current evidence suggests that these actin rings
precede axon specification, and may function in the development of a single axon during this
process (D’Este et al. 2015; Unsain, Stefani, and Cáceres 2018). Given the similar origins and
comparable structures, yet very different functions, of axons and dendrites, dendrite-axon
specification is a crucial process in neuronal development and will be covered in the following
section, as it plays into the structure and function of both of these structures.

Dendrite-axon specification:
During dendrite-axon specification, numerous intrinsic and extrinsic positive/negative feedback
signaling events are known to occur. It has been shown that the localized expression of the proteins
mPar3 and mPar6 are crucial for axon specification (Insolera, Chen, and Shi 2011). Both mPar3 and
mPar6 are PDZ domain-containing scaffold proteins, and rely on their PDZ domains for axon
specification (Insolera, Chen, and Shi 2011). The roles of many PDZ domain-containing proteins
extend throughout neuronal development, and will be addressed in detail later in this section.
Nonetheless, during dendrite-axon specification, mPar3 and mPar6 become strongly localized to the
newly forming axon and its growth cone, and ectopic expression of either of these proteins prevents
the formation of a distinct axonal projection from the cell (Nishimura et al. 2004). Additionally, in
many cases of generation of cell polarity, mPar3 and mPar6 associate with the kinase aPKC, and
form a complex crucial to the establishment of cell and embryo polarity (Suzuki and Ohno 2006).
This complex also appears to be relevant to neuronal polarity, as inhibition of aPKC activity inhibits
axon specification, much like what is observed following disrupted expression of mPar3 and mPar6
(Nishimura et al. 2004; Wiggin, Fawcett, and Pawson 2005). This mPar3/mPar6/aPKC complex has
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been shown to regulate small GTPase activity in neurons and other cells, and is believed to
contribute to the cytoskeletal changes that govern the formation of a mature axon (Wiggin, Fawcett,
and Pawson 2005; Nishimura et al. 2005). In fact, this complex can directly bind the GTPase Cdc42,
which has been shown to be required for normal axon development, and whose activity can directly
influence dendrite-axon specification (Nishimura et al. 2005; Joberty et al. 2000). Further, the
mPar3/mPar6/aPKC complex binds directly to Tiam1 and STEF (Tiam2), which are two guanine
nucleotide exchange factors (GEFs) that activate the Rho-family small GTPase, Rac1, yet another
protein crucial for the initiation of axon specification (Nishimura et al. 2005). Despite their wellestablished roles in neuronal polarity signaling, it has not yet been established whether the
mPar3/mPar6/aPKC complex lies upstream or downstream of the Rho-family GTPases in axon
specification, as each appears to be able to activate the other during this process (Wiggin, Fawcett,
and Pawson 2005; Nishimura et al. 2005; D. Lin et al. 2000). However, it remains true that
localization of the mPar3/mPar6/aPKC complex to the future axon, as well as localized activation of
Cdc42 and Rac1 in this region, both promote and are required for dendrite-axon specification in
neurons of the central nervous system (Shi, Jan, and Jan 2003; Schwamborn and Püschel 2004).

Upstream of the mPar3/mPar6/aPKC and Rho GTPase pathway is the kinase PI3K, which also
exhibits localized activation in the future axon during dendrite-axon specification. Localization of
activated PI3K to the future axon has been shown to be essential for axon specification, and
inhibition of the kinase via overexpression of its negative regulating protein, PTEN, prevents
neuronal polarization (Shi, Jan, and Jan 2003). Additionally, inhibition of PI3K activity prevents
localization of Par3 to the axon, which, in addition to regulating small GTPases and other
cytoskeletion-regulating proteins, is believed to be one mechanism by which PI3K influences axon
specification (Shi, Jan, and Jan 2003; Jiang et al. 2005). The role of PI3K activity in the recruitment of
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the mPar3/mPar6/aPKC complex during dendrite-axon specification also ties into the many extrinsic
factors that contribute to this process. Specifically, one of the primary extrinsic regulators of axon
specification is the neurotrophin family of molecules. This family includes molecules such as the
brain-derived neurotrophic factor (BDNF) and Neurotrophin-3, which activate the tyrosine receptor
kinase, TrkB, and promotes axon specification during neuronal development, whereas inhibition of
the TrkB receptor impairs it (Cheng et al. 2011; Nakamuta et al. 2011). PI3K lies downstream of TrkB
activation, which activates the Ras GTPase, a key regulator of PI3K activity (Shi, Jan, and Jan 2003).
In addition to neurotrophin signaling, the localized presence of transforming growth factor-β (TGF-β)
signaling also promotes axon specification (Yi et al. 2010). Interestingly, the impact of TGF-β
signaling on dendrite-axon specification has been shown to be dependent on the presence of
mPar6, as phosphorylation of mPar6 lies downstream of TGF-β receptor activation (Yi et al. 2010). In
summary, there are numerous crucial signal transduction events and morphological changes that
occur during axon and, in turn, dendrite specification prior to the signaling events and related
morphological impacts described in this work.

It is also worth noting that, in addition to the intrinsic and extrinsic signaling pathways described
here, there are many additional factors that have been observed to contribute to dendrite-axon
specification (Slit-Robo signaling, Ephrin signaling, adhesion molecules, and other Par proteins).
However, those related to the mPar3/mPar6/aPKC complex are currently the best understood, and
are thus the focus of this overview. To summarize, while the exact mechanisms underlying dendriteaxon specification are not fully understood, a combination of extrinsic and intrinsic factors converge
to generate neuronal polarity, and ultimately give rise to the formation of a singular axon and the
numerous dendrites that are characteristic of most neurons in the central nervous system. However,
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once specified, these structures continue to undergo numerous morphological changes before they
can begin to form and maintain the immensely complex network of cellular connections in the brain.
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Dendrite development after specification:
Following dendrite-axon specification, but before spine formation, there are several known
mechanisms which have been observed to underlie dendrite development and the formation of
adequately complex dendritic arbors. Much like the numerous intersecting pathways that contribute
to dendrite-axon specification, there are also many factors that combine to influence postspecification vertebrate dendrite development. The pathways best understood in this context, along
with those most closely related to the work described here, will be the focus of this section.

Transcriptional events influencing dendrite development:
In the nuclei of mammalian neurons, transcription factors such as Neurogenin 2, Cux1, and Cux2 all
contribute to the morphology of dendritic arbors (Dong, Shen, and Bülow 2015). Neurogenin 2
(Ngn2) has been shown to be required for the development of pyramidal neuron dendrites, and
neurons lacking Ngn2 form highly disorganized dendritic arbors (Hand et al. 2005). This function of
Ngn2 appears to be linked to the inhibition of the small GTPase RhoA, as two target genes of Ngn2
are RhoGAP5 and FNBP2, which both function to inhibit RhoA activity in neurons (Hand et al. 2005).
RhoA activity functions to inhibit dendritic outgrowth and branching through regulation of
cytoskeletal remodeling, and a more detailed analysis of the roles of these small GTPases in dendrite
development will be covered later in this section (Threadgill, Bobb, and Ghosh 1997). Like Ngn2, the
transcription factors Cux1 and Cux2 are also required for normal dendrite development, and mice
lacking these transcription factors develop neurons with significantly reduced dendrite length and
branch number (Cubelos et al. 2010). Cux1 and Cux2 are believed to impact dendrite morphology
through the upregulation of β-actin protein expression, a protein with established roles in dendrite
elongation (Cubelos et al. 2010; Ammer and Weed 2008). Additionally, while it is not yet fully
understood how Cux1 and Cux2 regulate dendrite morphology beyond their regulation of β-actin
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expression, two of their target genes, Xlr4b and Xlr3b, contribute to dendritic spine development
and function in mammalian neurons (Cubelos et al. 2010). While there have not yet been many
studies on the roles of mammalian transcription factors in the development of dendrites, the
observations described above, combined with similar findings in invertebrate model organisms,
primarily Drosophila, make it clear that transcriptional regulation of neuronal genes play a key roles
in the formation of dendritic arbors during development (Dong, Shen, and Bülow 2015).

Extrinsic factors influencing dendrite development:
In additional to transcription events in the nuclei of neurons, several extrinsic factors also contribute
to early dendrite development. Interestingly, many of these extrinsic signaling cues also have roles
in axon specification, as described above. For instance, several members of the neurotrophin family
of signaling molecules, which includes nerve growth factor (NGF), brain-derived growth factor
(BDNF), neurotrophin-3, and neurotrophin-4, have been found to contribute to dendritic elaboration
(McAllister, Lo, and Katz 1995). These molecules influence dendrite development via activation of
members of the tyrosine receptor kinase (Trk) family of receptor proteins, as described above
(Huang and Reichardt 2003). Specifically, neurons lacking the BDNF receptor, TrkB, or having
disrupted TrkB localization, develop very simplistic, under-branched and under-extended dendrites
(B. Xu et al. 2000; Zhou et al. 2012). Likewise, loss of the neurotrophin-3 receptor, TrkC, also results
in the development of dendrites of severely reduced complexity, although in certain contexts,
neurotrophin-3 signaling has been found to inhibit dendritic branching (Joo, Hippenmeyer, and Luo
2014; McAllister, Katz, and Lo 1997). Downstream of Trk activation, Phosphoinositide 3-kinase (PI3K)
is activated, which in turn activates the mPar3/mPar6/aPKC complex (PAR Complex), resulting in the
downstream inhibition of glycogen synthase kinase-3beta (GSK3β) via serine phosphorylation (Rui et
al. 2013). In hippocampal neurons, inhibition of GSK3β results in the elaboration of dendritic arbors,
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whereas activation leads to the formation of simple protrusions with significant reductions in length
when compared to controls (Rui et al. 2013). This Trk-mediated inhibition of GSK3β is believed to
impact dendrite elaboration via several mechanisms, including the regulation of multiple
transcription factors involved in neuronal development, such as CREB and neurogenin 2, as well as
influencing cytoskeletal dynamics through the mediation of the activity of microtubule-associated
protein (MAPs), such as APC (Zhou et al. 2012; Grimes and Jope 2001). Because of the vast roles of
GSK3β in the regulation of developmental processes in neurons, and its strong link to the Trk
receptors and their neurotrophin ligands, the neurotrophin family of signaling molecules are wellpositioned to be key regulators of dendritic morphology and ultimately neuronal connectivity.

It worth noting that, in addition to neurotrophin signaling, multiple other extrinsic pathways that
influence dendrite development are theorized to also converge on GSK3β to regulate gene
transcription and cytoskeletal dynamics, and thus dendrite morphology. For instance, activation of
the Wnt signaling pathway in neurons also results in the inhibition of GSK3β and has been shown to
contribute to the elaboration of dendritic arbors, and overexpression of the Wnt receptor, Frizzled
(Fz7), results in the formation of more complex arbors (Rosso et al. 2005; Y. T. Kim et al. 2011).
However, a detailed understanding of how Wnt-mediated GSK3β inhibition intersects with the
activity of other known neuronal mediators of GSK3β in dendrite development remains yet to be
established. Indeed, perhaps the best characterized role of Wnt signaling in dendrite development is
through the activation of actin regulatory proteins such as CaMKII and Rac1 (Rosso et al. 2005;
Ferrari et al. 2018). In this pathway, locally secreted Wnt7b binds and activates the dynamically
expressed Fz7 receptor along dendrites, and results in the recruitment of the scaffold protein
Disheveled (Dv1) to the membrane (Ferrari et al. 2018). This dendritically localized Dv1 colocalizes
with F-actin and can induce cytoskeletal changes through multiple known mechanisms. It can form a
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complex with, and activate, the Rho-family small GTPase Rac1, which initiates actin cytoskeleton
reorganization and contributes to dendrite elaboration (Esufali, Charames, and Bapat 2007;
Threadgill, Bobb, and Ghosh 1997). Additionally, Dv1 has been found to activate CaMKII and JNK
(Jun Kinase), both of which are known regulators of microtubule-associated proteins (MAPs),
microtubule dynamics, and dendrite complexity (Ferrari et al. 2018). Taken together, these findings
support a role of Wnt signaling in the growing field of extrinsic cues known to influence dendrite
development, though many questions, such as how this pathway contributes to localized versus
global changes in dendrite morphology, remain unanswered. Interestingly, the effects of this Wnt
pathway appear to be specific to dendrites, as researcher found no effects on axon morphology in
response to perturbations of Wnt7b signaling, despite Disheveled having known roles in axon
specification and elongation (Rosso et al. 2005). These findings suggest that despite the presence of
similar signaling components, these two compartments respond differently to extrinsic cues, with
their responses being mediated by spatially or temporally regulated changes in the composition of
intracellular signaling machinery populations.

Believed to act in tandem with the neurotrophin and Wnt-signaling pathways described above,
several other extrinsic cues have also been observed to function in establishing dendrite
morphology during development. One such group of molecules is the Semaphorin family of secreted
growth factors. Like the neurotrophins, several Seamphorin family members also play key roles in
axon development, with functions in processes including outgrowth and pathfinding (Winberg et al.
1998). In dendrites, Semaphorin 3A and its receptors, neuropilin-1 and PlexinA, have all been
observed to promote the branching of dendritic protrusions during development, both in vitro and
in vivo (Tran et al. 2009). This is believed to occur through the activation of a variety of downstream
effectors, including Rac1 and Jun Kinase (JNK), both of which function to promote dendrite
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branching (Cheadle and Biederer 2014; Ben-Zvi et al. 2006; Rosso et al. 2005). Semaphorin 3A
signaling also results in the recruitment and activation of the Ca(V)2.3 calcium ion channel in
dendrites via the triggering of increased production of the cGMP signaling molecule, which has been
shown to promote dendritic outgrowth (Nishiyama et al. 2011). While the mechanism by which this
Ca(V)2.3 channel-dependent role of Semaphorin 3A in dendrite development occurs remains to be
determined, activation of Ca(V)2.3 activation in dendrites contributes to the recruitment of the
dendritic microtubule-associated protein, MAP2, suggesting that this pathway likely mediates the
microtubule dynamics of dendrites (Nishiyama et al. 2011). In addition to inducing cytoskeletal
changes, Semaphorin 3A signaling also results in the recruitment of AMPA glutamate receptors and
synaptic proteins, such as PSD-95, to the dendrite, suggesting that Semaphorin signaling perhaps
contributes to both the branching and elongation of dendrites as well as their maturation in the
context of forming post-synaptic densities along their lengths (Morita et al. 2006; Yamashita et al.
2014).

In the context of extrinsic growth cues, the neurotransmitter glutamate has also been strongly
implicated in several aspects of dendrite development. Both diffuse glutamate treatment and more
localized glutamate-induced activity have been shown to contribute to the elaboration of dendritic
arbors in several contexts. Cultured primary hippocampal neurons treated with glutamate develop
significantly more complex dendritic arbors when compared to controls, whereas blocking activity of
either NMDA or AMPA receptors in cultured neurons results in the formation of less complex
dendritic arbors (Hamad et al. 2011; Charych et al. 2006; Previtera and Firestein 2015b). Loss of
NMDA receptor function in vivo results in similar reductions in dendrite length and complexity in
mouse retinal ganglion cells (Elias et al. 2018). Further, pyramidal neurons of mice lacking Grm5, the
gene that encodes the glutamate receptor mGluR5, develop significantly less complex dendritic
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arbors than controls, suggesting that glutamate signaling can mediate dendrite morphology via
several receptors/mechanisms (Loerwald et al. 2015). Interestingly, the mechanisms by which
glutamate induces changes in dendrite morphology remain almost entirely unknown, though the
neurotransmitter’s roles in dendritic spine formation are better understood and may shed light on
its means of action in dendrites. In these structures, glutamate signaling, via NMDA receptors,
results in a transient increase in local calcium concentrations and the activation of calmodulin
(CaM). This ultimately leads to remodeling of the actin cytoskeleton of the spine via activation of
Rac1, a Rho-family GTPase, by kalirin-7, a GTPase activating protein downstream of CaM activity (Xie
et al. 2007; Soderling 2000). It is possible that glutamate’s influence on dendrite development may
be mediated through a similar calcium and/or Rho-family GTPase-dependent pathway, though more
work needs to be completed in the study of dendrite development before the role of glutamate
signaling can be fully elucidated. Further, while the roles of the extrinsic cues described here have
provided significant advancements in our understanding of dendrite development, how these
pathways contribute to specific changes in dendrite morphology (i.e. branching vs. elongation),
remain to be uncovered. Nevertheless, these findings demonstrate a key role of extrinsic signaling in
dendrite development through their mediation of intrinsic changes in neurons at both the
transcriptional and structural levels.

Intrinsic factors influencing dendrite development:
As briefly mentioned above, and in addition to transcriptional regulation of key genes, there are
many cytoskeletal changes initiated by extrinsic cues that dendrites undergo during their
development. Many of the pathways involved in dendrite development discussed above converge
on the modulation of the Rho GTPase family of cytoskeletal regulatory proteins, and the cytoskeletal
dynamics brought about by these pathways are what ultimately give rise to the morphological
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changes that underly dendrite development. RhoA, along with two other members of the Rho family
of small GTPases, Rac1 and Cdc42, have all been strongly implicated in the formation and
elaboration of dendritic arbors during neuronal development. These proteins act as molecular
switches for downstream effectors as they cycle between their GDP-bound inactive state and their
GTP-bound active state (Threadgill, Bobb, and Ghosh 1997). Rho-family GTPases are typically
activated by a guanine exchange factor (GEF) protein, which functions to facilitate the exchange of
GDP for GTP (Schmidt and Hall 2002). Once active, the Rho-family GTPases regulate actin
cytoskeleton remodeling through the direct and indirect activation of several proteins/complexes,
such as ROCK, LIMK, Cofilin, Arp2/3 and WAVE, all of which can directly or indirectly mediate
cytoskeletal dynamics (Maekawa et al. 1999; T. Lin et al. 2003; Nakanishi et al. 2007; Miki, Suetsugu,
and Takenawa 1998).

In the context of dendrite development, the GTPase RhoA has been found to negatively regulate
dendrite branching and outgrowth. Expression of a constitutively active RhoA results in dendritic
arbors of significantly reduced size in rat hippocampal neurons and Xenopus retinal ganglion cells
(AY Nakayama, Harms, and Luo 2000; Ruchhoeft et al. 1999). Expression of a dominant-negative
RhoA conversely results in the development of significantly longer dendritic arbors in mouse
hippocampal neurons and Xenopus optic tectal neuron when compared to controls (Ahnert-Hilger et
al. 2004; Li, Van Aelst, and Cline 2000). It has been shown that RhoA can influence cytoskeletal
remodeling through the activation of formin proteins, such as mDia, which directly stabilize
microtubules and promote actin polymerization, as well as through the activation of Rho-kinase
(ROCK), which is believed to be the primary mechanism by which RhoA prevents dendritic
outgrowth (Lammers et al. 2008; M Amano et al. 1998; Hirose et al. 1998; Govek, Newey, and Van
Aelst 2005). Activation of ROCK by RhoA leads to the phosphorylation and inactivation of the
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microtubule associated proteins Tau and MAP2, potentially contributing to cytoskeleton instability
in neuronal projections (Mutsuki Amano et al. 2003). RhoA-mediated activation of ROCK also leads
to the phosphorylation and activation of the regulatory myosin light chain, MLC, which is believed to
promote neurite retraction via actomyosin contraction (M Amano et al. 1998). Additionally,
inhibition of ROCK has been shown to rescue the dendritic phenotypes that result from increased
RhoA activity, suggesting that ROCK represents a crucial effector of RhoA in establishing dendrite
morphology (M Amano et al. 1998; Hirose et al. 1998). Another potential mechanism by which RhoA
prevents dendritic growth is via the inhibition of cypin, a guanine deaminase that has been shown to
promote dendritic branching through its direct interaction with microtubules and subsequent
facilitation of their assembly (Akum et al. 2004). Taken together, the many mechanisms by which
RhoA mediates dendrite retraction and inhibition of dendrite outgrowth implicate it as a key
regulator of dendrite morphology. Given the vast roles of RhoA in mediating actin and microtubule
dynamics, further study is surely required to fully understand the role of this protein in dendrite
development.

The Rho-family GTPases Rac1 and Cdc42 have somewhat antagonistic roles to RhoA in the context of
dendrite growth and branching. Expression of constitutively active Rac1 or Cdc42 in rat hippocampal
neurons results in the formation of significantly longer and more highly branched dendrites when
compared to controls (Threadgill, Bobb, and Ghosh 1997). Constitutive Rac1 activation of Rac1
results in a similar increase in dendrite length and complexity in Xenopus retinal ganglion cells as
well (Ruchhoeft et al. 1999). Moreover, expression of dominant negative Rac1 or Cdc42 mutants in
both Xenopus retinal ganglion cells and mouse pyramidal neurons results in a drastic decrease in
dendritic arbor complexity, suggesting that both of these proteins are required for dendrite
branching during neuronal development (Ruchhoeft et al. 1999; Hayashi, Ohshima, and Mikoshiba
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2002). Both Rac1 and Cdc42 act downstream of multiple extrinsic signaling pathways, and are crucial
components of neurotrophin signaling during dendrite development. Following activation of the Trk
receptors by neurotrophin ligands, which results in RhoA inhibition and Rac1/Cdc42 activation (as
described above), Rac1 and Cdc42 go on to mediate activity of several actin and microtubule
associated effector proteins. Both proteins activate members of the p21-activated kinase (PAK)
family, which have been shown to induce neurite formation in PC12 cells and in cortical neurons
(Daniels, Hall, and Bokoch 1998; M Nikolic et al. 1998). These functions of PAK proteins likely occur
through the direct and indirect inhibition (via phosphorylation) of cytoskeleton-associated proteins
such as cofilin and OP18. Inhibition of cofilin leads to actin polymerization and inactivation of OP18
prevents the protein’s destabilization of microtubules, thereby increasing microtubule stability and
growth (Maekawa et al. 1999; Sumi et al. 1999; Ohashi et al. 2000; T. Amano et al. 2001; Daub et al.
2001; Cassimeris 2002; Wittmann, Bokoch, and Waterman-Storer 2003). Additionally, Rac1 and
Cdc42 both indirectly activate the Arp2/3 protein complex, which can associate with actin filaments
and promote polymerization and ultimately dendrite branching (Eden et al. 2002; Machesky and
Insall 1999; Rohatgi et al. 1999). This GTPase-mediated Arp2/3 activation occurs through activation
of WASP by Cdc42 and WAVE by Rac1, with perturbation of either pathway abolishing the impact of
Rac1 and Cdc42 activity on dendrite morphology (Tahirovic et al. 2010; Banzai et al. 2000). Taken
together, the ability of Rac1 and Cdc42 to mediate cytoskeletal dynamics through multiple
downstream effectors, as well as the convergence of numerous upstream pathways, each with
known roles in dendrite elaboration, on these proteins implicates them as crucial regulators of
dendrite development. Given the vast roles of the Rho family of GTPases, achieving a better
understanding of their regulation during neuronal development will be a key step in revealing the
mechanisms that underlie dendrite function and many neurodevelopmental disorders.
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Lastly, at the dendritic membrane, several non-receptor proteins have been shown to influence
dendrite development, with the cadherin family of proteins having perhaps the best understood
roles in this context. The cadherin family represents a large family (115 members) of membrane
proteins with extensive functions in cell adhesion and signaling (Seong, Yuan, and Arikkath 2015).
The classical cadherins are best characterized by their associations with beta-catenin and alphacatenin to form the cadherin-catenin complex, which serves as the primary link between the
extracellular environment and the actin cytoskeleton of cells (Yamada et al. 2005). Members of the
cadherin protein family each contain an extracellular cadherin (EC) domain, which is largely
responsible for forming connections with other cells via dimerization with their respective cadherins
(Shapiro and Weis 2009). Through their interactions with the extracellular environment, cadherins
participate in the initiation of intracellular signaling cascades that govern cell behavior and shape
(Seong, Yuan, and Arikkath 2015). In the context of neuronal development, N-cadherin, a classical
cadherin first discovered in neurons, has been implicated in the outgrowth and elaboration of
dendrites (Tan et al. 2010). Inhibition of N-cadherin’s ability to form extracellular interactions results
in a dramatic reduction in dendrite complexity in the CA3 region of hippocampal slices (Bekirov et al.
2008). Likewise, expression of the isolated EC domain of N-cadherin, which can bind N-cadherin of
other cells, but fails to link the homodimer to the actin cytoskeleton, results in a similar reduction in
overall dendrite length and branch number in cultured rat hippocampal neurons (Tan et al. 2010).
Interestingly, loss of other members of the classical cadherin-catenin complex, such as p120-catenin,
delta-catenin, beta-catenin, or alpha-catenin also result in atypical dendrite morphology (Tan et al.
2010; Arikkath et al. 2008a; Elia et al. 2006; Yu and Malenka 2003). In addition to N-cadherin,
several protocadherins (non-classical cadherin family members) have been similarly implicated in
dendrite development. Promoting the dimerization of protocadherins in cortical neurons has been
found to increase dendritic arbor complexity, whereas perturbing such interactions reduces

23

dendritic arbor complexity in these cells (Molumby, Keeler, and Weiner 2016). Taken together,
these observations suggest that the cadherin family of proteins, as well as other members of the
cadherin-catenin complex have key roles in the formation of dendritic arbors, yet much remains to
be discovered surrounding the functions of these proteins.

Summary of dendrite development:
In summation of the pathways described here, dendrite development is an incredibly complex
process dependent on the highly coordinated intersections of extrinsic signaling cues and intrinsic
transcriptional and structural changes within a neuron. Prior to dendritic arbor elaboration and
synapse formation, axon-dendrite specification occurs, which begins the specification of roles of the
two primary types of neuronal protrusions. While this specification event is a crucial point in
dendrite development, the work described here focuses on the morphological changes that occur
after specification. Following axon-dendrite specification, dendrites undergo significant
morphological changes as they develop into the iconic complex arbors that receive nearly all of the
synaptic transmissions in the central nervous system. Despite the significance of dendrite
morphology in the overall connectivity and function of the nervous system, much remains unknown
about how these structures develop prior to the formation of synapses. Many of the pathways
described above contribute to both dendrite elongation and dendrite branching, though these two
events serve different roles in establishing neuronal connectivity and are likely mediated by distinct
mechanisms. Developing a better understanding of the decision of a dendrite to branch or elongate,
and how these decisions are mediated by external cues throughout development, will provide
valuable insight into normal neuronal development and the numerous neurodevelopmental
disorders that result from atypical dendrite morphology, and may lead to new therapeutic targets
for these disorders. Through the work described here, I reveal a pair of novel protein-protein

24

interactions involving the p120-catenin family member, delta-catenin, that function to integrate
external dendritic growth factors with intracellular pathways that appear to converge on actin
regulatory proteins and ultimately contribute to the countless elongation and branching events that
occur throughout early dendrite development.
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p120-catenin protein subfamily:
Catenins are a family of proteins, most famously known for their interactions with classical
cadherins as part of the catenin-cadherin complex (Shapiro and Weis 2009). The p120-catenin
subfamily of catenins contains four members: p120-catenin, ARVCF catenin, p0071, and deltacatenin, all of which possess diverse roles in the development of the nervous system and other
tissues (McCrea and Park 2007). Like most catenins, members of the p120-catenin family contain a
series (usually 9 to 12) of ARM repeats, which comprise the Armadillo domains of these proteins
(Figure 2). These ARM repeats, about 42 amino acids in length, each contain three alpha helices that
fold into a super-helix of helices to form the larger Armadillo domain (Huber, Nelson, and Weis
1997; Anastasiadis and Reynolds 2000). The Armadillo domains of catenins are responsible for
interactions with cadherin proteins found in all tissues and are central to many of the adhesive and
signal transduction roles of these proteins. In the case of the p120-catenin subfamily, the Armadillo
domain functions to stabilize cadherins at the membrane and prevent their endocytosis, thereby
regulating the adhesive behaviors of the cell (Davis, Ireton, and Reynolds 2003; Kowalczyk and
Reynolds 2004). In addition to their shared Armadillo domains, three members of the p120-catenin
family, ARVCF-catenin, p0071-catenin, and delta-catenin, each contain a PDZ-binding motif at their
C-terminus, which is capable of interacting with the PDZ domains of many proteins important for
the signaling events in various tissues during development (McCrea and Park 2007). These PDZdependent interactions have diverse roles in development, ranging from stabilization of structures
such as synapses, to regulation of subcellular localization and transcriptional activity of the catenin
proteins (Arikkath et al. 2008b; Kausalya, Phua, and Hunziker 2004; Ide et al. 1999). Lastly, along
with mediating cell adhesion through associations with the cadherins, many catenin proteins,
including members of the p120-catenin subfamily, are also known to respond to Wnt signaling, a
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Figure 2. Schematic of members of the p120-catenin subfamily of proteins.

The p120-catenin subfamily includes delta-catenin, ARVCF, p0071, and p120-catenin. Each member
contains a central ARM domain composed of Armadillo repeats, enabling the protein to form
interactions with adhesion proteins, such as the cadherins. Unlike p120-catenin, delta-catenin,
ARVCF, and p0071 contain a PDZ-binding motif at their respective C-termini that allows them to
interact with PDZ domain-containing proteins.
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pathway previously implicated in both dendrite and axon development (Rosso et al. 2005; Bian et al.
2014; Ferrari et al. 2018; McCrea and Park 2007).

The namesake of this family, p120-catenin, is crucial for embryogenesis, with knockout of p120catenin in mice resulting in embryonic lethality (Davis and Reynolds 2006). While many of the
developmental roles of p120-catenin stem from its maintenance of membrane cadherins, it has also
been shown to be a key regulator of Rho-family GTPase activity. P120-catenin activates Rac1 and
Cdc42, and contributes to the recruitment of active Rac1 to cadherin-mediated cellular junctions
(Noren et al. 2000; Grosheva et al. 2001). P120-catenin also directly interacts with and inhibits RhoA
activity by blocking the GDP-GTP exchange of RhoA (Anastasiadis et al. 2000). Finally, p120-catenin
is also known to function as a transcriptional regulator in the nucleus, where it directly interacts
with the transcriptional repressor Kaiso and relieves the repression of its target genes (Daniel and
Reynolds 1999; J.-I. Park et al. 2005). In conditional knockout models, p120-catenin was
demonstrated to be required for the development and maintenance of epithelial tissues such as
vertebrate skin, in which p120-catenin’s stabilization of cadherins contributes to barrier function
and junction stability, and in cardiovascular tissues, where its stabilization of cadherins is crucial for
vascular integrity and endothelial cell proliferation (Perez-Moreno et al. 2006; Xiao et al. 2003; Oas
et al. 2010). P120-catenin has also been implicated as a potential oncogene, as it has been shown to
induce increased metastasis and tumor growth in certain breast cancers (Soto et al. 2008; Reynolds
et al. 1994). This is believed to occur through either the stabilization of mesenchymal cadherins,
activation of Rho-family GTPases, or through association with the transcriptional repressor Kaiso in
the nuclei of cancer cells, as all of these mechanisms have been linked to tumor growth and invasion
(Soto et al. 2008; Reynolds et al. 1994; Jones et al. 2012; Vermeulen et al. 2012). In the nervous
system, p120-catenin has been found to influence dendritic spine development, and loss of p120-
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catenin in mouse hippocampal neurons results in a reduced amount of dendritic spines and
synapses along dendrites in these cells. It is believed that this function of p120-catenin occurs
through the combination of stabilization of neuronal cadherins, activation of Rac1, and inactivation
of RhoA in developing dendrites. (Elia et al. 2006).

While less understood than their catenin relatives, ARVCF-catenin and p0071-catenin both have
established roles in adherens junction formation and vertebrate development. Notably, loss of
ARVCF-catenin has been strongly linked to Velo-Cardio-Facial syndrome (VCFS), a developmental
disorder resulting in craniofacial and cardiovascular defects in humans (Sirotkin et al. 1997). ARVCFcatenin depletion in Xenopus embryos results in gastrulation defects, likely stemming from the
protein’s modulation of Rho-family GTPases and cadherin stability, as expression of dominantnegative RhoA, constitutively active Rac1, or overexpression of C-cadherin can rescue these defects
(Fang et al. 2004). The roles of p0071-catenin, on the other hand, are not nearly as well understood
as those of its relatives, though the protein has been found to function in the activation of RhoA
during cytokinesis, with loss of p0071-catenin resulting in the induction of apoptosis during this
process (Keil et al. 2007). Given the roles of p0071-catenin in cellular processes, it will be interesting
to reveal the developmental roles of this protein, though much additional work is required in this
area. Lastly, the final member of the p120-catenin family, delta-catenin, has roles in development
mostly exclusive to the central nervous system, and will be described in detail in the following
section, as it is the primary focus of this work. Overall, members of the p120-catenin family of
proteins have diverse and crucial functions throughout vertebrate development. In many cases,
these proteins act as key regulators of cell signaling and tissue specification, making further study of
the proteins essential for developing a better understanding of these processes.
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delta-catenin
Of the p120-catenin protein subfamily, delta-catenin has the most well-established roles in the
central nervous system, and its expression is almost entirely localized to this region (Ho et al. 2000).
Delta-catenin is a 150kD protein that, as previously mentioned contains an Armadillo domain
composed of ARM repeats, as well as a C-terminal PDZ-binding motif. The Armadillo domain of
delta-catenin binds to N-cadherin, as it does to several other proteins important for neural
development and function (Gu et al. 2009; Yuan et al. 2015). The PDZ-binding motif of delta-catenin
is a highly-conserved region (General: xSxV; delta-catenin: DSWV) at its C-terminus that can
recognize and bind several PDZ domain-containing proteins crucial for neural development (Yuan et
al. 2015). Most notably, the PDZ-binding motif of delta-catenin interacts with the PDZ proteins Erbin
and Magi2/S-SCAM, which are necessary for dendrite extension/branching and synapse
development, respectively (Arikkath et al. 2008b; Ide et al. 1999). Interestingly, proteomic analysis
of the developing rat brain has revealed a pair of phosphorylation sites (S1245 and S1242) within
the PDZ-binding motif of delta-catenin, although the function of these phosphorylation events
remains unknown (Lundby et al. 2012). Nevertheless, there is precedence for the importance of
these phosphorylation sites, as catenin proteins are known to be targets of post-translational
modifications that alter their functional properties (Gottardi and Gumbiner 2004).

As briefly mentioned above, delta-catenin is highly expressed in the central nervous system
throughout development and into adulthood (Ho et al. 2000). Like the other p120-catenin family
members, delta-catenin has both structural and signaling roles within cells, and functions in many
facets of cell development, particularly in the development of cells within the central nervous
system. Namely, a delta-catenin knockout mouse model develops cognitive deficits (primarily in
learning and memory) and has severe defects in dendritic morphology, as well as synaptic plasticity,
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demonstrating the roles of delta-catenin in early brain development and beyond (Israely et al. 2004;
Matter et al. 2009). In both hippocampal neuron cultures and in vivo, delta-catenin has been shown
to regulate both dendrite elongation and branching during development, with these functions being
believed to occur via dynamic modulation of the GTPases Rac1, Cdc42, and RhoA, resulting in
downstream alterations in the actin cytoskeleton (Martinez et al. 2003). Additionally, in neuronal
cultures, delta-catenin has been shown to be required for normal dendrite development, with
shRNA-mediated knockdown of delta-catenin leading to inhibition of both dendrite elongation and
branching (Arikkath et al. 2008a; Martinez et al. 2003). Moreover, overexpression of delta-catenin in
NIH 3T3 cells, as well as in other non-neuronal cells, leads to the formation and branching of
dendrite-like processes, which has been linked to the remodeling of actin and microtubules (H. Kim,
Han, et al. 2008; K. Kim et al. 2002). Lastly, delta-catenin has been implicated in several
neurodevelopmental disorders, with perturbations in the protein’s normal functioning being
associated with cognitive disorders such as cri-du-chat syndrome, autism, and schizophrenia
(Medina et al. 2000; Turner et al. 2015; Vrijenhoek et al. 2008). These roles of delta-catenin position
it to be a key regulator of neuron development, specifically in the context of dendritic arbor
formation. Developing a better understanding of how delta-catenin contributes to both dendrite
elongation and branching will provide new avenues for research into neuronal development and
potentially into new therapeutic targets for several neurodevelopmental diseases.

MAGUK protein family, Magi1, and Pdlim5:
The Membrane-Associated Guanylate Kinase (MAGUK) family of proteins represents a large group of
proteins with both scaffolding and signaling roles in cellular function. Members of this family contain
at least one PDZ (PSD-95, DLG, ZO-1) domain, a Src Homology 3 (SH3) domain, and an inactive
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Guanylate Kinase (GK) domain (Oliva et al. 2012). The PDZ domain of these proteins are typically 80100 amino acids in length and are composed of six beta-sheets, one long alpha-helix, and one shortalpha helix, with the beta-sheets and long alpha-helix forming a binding pocket for PDZ-binding
motifs, like the one found in delta-catenin (H. J. Lee and Zheng 2010). These PDZ domains are
required for many of the functions of MAGUK proteins, and represent key points of regulation in
many pathways. Notably, the Wnt signaling pathway described above, which contributes to dendrite
elaboration, is dependent on the PDZ domains of Disheveled, a PDZ domain-containing scaffold
protein that functions downstream of Wnt7b signaling (Rosso et al. 2005). Arguably the best studied
members of the MAGUK family are the Zona Occludens proteins (ZO-1, ZO-2, and ZO-3) and
postsynaptic density protein 95 (PSD-95), all of which have crucial roles at cell junctions. The Zona
Occludens proteins have three PDZ domains, each of which are required for the formation and
function of tight junctions through the recruitment of transmembrane claudins proteins (Umeda et
al. 2006). PSD-95 similarly functions in the assembly and maintenance of cell junctions via
interactions with its PDZ domains, though largely in the context of synapses in the nervous system.
PSD-95 is highly localized to the post-synaptic density, where it is important for the stabilization and
organization of several proteins, such as NMDA and AMPA receptors (Kornau et al. 1995; Bats, Groc,
and Choquet 2007). Because of this, PSD-95 acts as a key regulator of synaptic strength and
remodeling, and is crucial for synapse formation (Bats, Groc, and Choquet 2007; X. Chen et al. 2015,
2011). Taken together, members of the MAGUK family of proteins have established roles in the
function and organization of protein complexes found at the cell membrane and at cellular
junctions. The importance of MAGUK proteins’ PDZ domains for many of their functions in
membrane signaling warrants further research into the potential significance of these domains in
other areas of biology, particularly dendrite development, as this process is highly dependent on the
transduction of signals from the cell membrane to the cytoskeleton of neurons.
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Magi1
Magi1 is a neural member of the membrane-associated guanylate kinase, or MAGUK, subfamily of
PDZ proteins. Magi1 contains six PDZ domains, a GUK domain, and two WW motifs (Figure 3). Like
its relatives, Magi1 has been implicated in synaptic maintenance, in which it is believed to act as a
scaffold for the transmembrane adhesion protein, Sidekick-2 (Yamagata and Sanes 2010). However,
most previous studies on Magi1 have focused on non-neuronal tissues, where it functions as a
scaffold at cellular junctions of epithelial cells, as well as acting as a tumor suppressor
(Dobrosotskaya and James 2000). Recently, a Magi1 knockout mouse has been developed to
investigate the roles of this protein in the cardiovascular system, and has revealed potential roles for
the protein in stress-mediated responses of endothelial cells in cardiac tissues (Abe et al. 2019).
While the neurological effects of Magi1 loss in vivo have yet to be investigated, given the effects
observed in vitro, described below, it will be interesting to see if these mice develop cognitive
anomalies in response to Magi1 loss. In primary rat dorsal root ganglion cell cultures, Magi1 localizes
to the growth cones of developing neurites, while in PC12 rat pheochromocytoma cells, RNAimediated knockdown of Magi1 leads to a loss of nerve growth factor (NGF)-induced neurite
outgrowth (Ito et al. 2013). Magi1 copy number variation has also been associated with both bipolar
disorder and schizophrenia, providing further evidence of the protein’s significance in neuronal
development (De Moor 2015; Karlsson et al. 2012). Despite these
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Figure 3. Schematic of Magi1 and other members of the MAGUK protein family.

Magi1 contains six PDZ domains, lending to its function as a scaffold protein, as well as a pair of WW
domains. Magi1, Magi2, and Magi3 share a similar protein domain schematic, but have surprisingly
low homology and fulfill different functions in various tissues. PSD-95 is a MAGUK protein family
member with well-established roles as a synaptic scaffolding protein.
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findings on the involvement of Magi1 in neurite extension, the mechanisms underlying the protein’s
role in dendritogenesis remain unclear.

Pdlim5
Pdlim5, like Magi1, is a PDZ protein that has enriched expression in neural tissues. While not a
member of the MAGUK protein family, it contains one PDZ domain and three LIM (Lin11, Isl-1 &
Mec-3) domains, each enabling protein-protein interactions relevant to neural development (Figure
4). Pdlim5 has been suggested to function in the restriction of dendritic spine growth through an
interaction with Spine Associated RapGAP (SPAR) via the LIM2/3 domain of Pdlim5 (Herrick et al.
2010). While not much is known about protein interactions with the PDZ domain of Pdlim5, it has
been shown to interact with the actin-binding protein alpha-actinin in cardiomyocytes, and is crucial
for heart development (Nakagawa et al. 2000). While homozygous knockout of Pdlim5 is lethal in
mouse models, largely due to embryonic heart failure, a heterozygous loss of the protein results in
significantly increased immobility in forced swim tasks, a behavior often linked to depression
(Horiuchi et al. 2013). Further, administration of antidepressents in mice has been shown to result in
increased Pdlim5 expression in the hippocampus, suggesting a role for this protein in network
remodeling (Horiuchi et al. 2013). Additionally, like Magi1, Pdlim5 localizes to the growth cones of
neurite tips in primary neuron cultures. However, while Magi1 is thought to contribute to neurite
outgrowth, Pdlim5 has been found to promote growth cone collapse via the translocation of PKCε to
the membrane (Ren et al. 2015). In line with in vivo results from mouse models, Pdlim5 has also
been implicated in the progression of several neurological conditions, including schizophrenia,
bipolar disorder, and major depression, although its role in the onset of these maladies remains
unclear (Horiuchi et al. 2006, 2013; Kato et al. 2005).
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Figure 4. Schematic of Pdlim protein family.

All Pdlim proteins contain a single N-terminal PDZ domain, and at least one C-terminal LIM domain.
Pdlim proteins 1-4 contain only a single LIM domain, whereas Pdlim5, Pdlim6, and Pdlim7 each
contain three LIM domains.

36

Chapter II

Results

37

Part One: Identification of novel phospho-dependent interactions formed by delta-catenin

Identification of phosphorylation sites in the PDZ-binding motif of delta-catenin:
Given the numerous roles of delta-catenin in neuronal development, I sought to identify novel
partners of delta-catenin that might help explain the function of delta-catenin in the elaboration of
dendrite morphology. Based upon the literature, delta-catenin interacts with several PDZ domaincontaining proteins, among others, during neuronal development (Yuan et al. 2015; Ide et al. 1999;
Arikkath et al. 2008a). These interactions are entirely dependent on the PDZ-binding motif of deltacatenin, which is present at the protein’s extreme C-terminus. Analysis of this region reveals a 100%
conserved identity across multiple species (human, mouse, rat, chicken, frog, and fish). This suggests
that the PDZ-binding motif of delta-catenin plays a crucial role in the protein’s function. Further, the
closest relative to delta-catenin (CTNND2), p120-catenin (CTNND1), lacks this motif, providing
further evidence that this region gives rise to roles and functions unique to delta-catenin. I noticed
that the PDZ-binding motif of delta-catenin contains two conserved phospho-serines at its extreme
carboxyl-terminus (e.g. mouse S1242 and S1245) (Figure 5), that importantly have been observed to
be phosphorylated in vivo (Lundby et al. 2012). Please note that to enable me to speak in a uniform
way about these residues across species, I refer to them as being at the -6 and -3 positions (w/ the 1 position being delta-catenin’s carboxyl-terminal valine) for the remainder of this work.
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Figure 5. Conservation of the C-terminus of delta-catenin across species.

The PDZ-binding motif of delta-catenin is fully conserved across human, mouse, rat, chicken, frog,
and fish. This region contains a pair of phosphorylation sites at S1245 (-3) and S1242 (-6) that are
phosphorylated in vivo.
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Delta-catenin interacts with Magi1 and Pdlim5 in a phospho-dependent manner:
In other published examples, phosphorylation events within a PDZ-binding motif can alter the ability
of the motif to bind partner proteins (H. J. Lee and Zheng 2010; Chung et al. 2000; A. B. Espejo et al.
2017). I chose to utilize protein-domain microarrays to help reveal novel PDZ-domain proteins that
bind to delta’s PDZ-binding motif, and to test if phosphorylation at the -6 and/ or -3 serine positions
of delta has an impact upon such interactions. Such arrays excel at revealing the importance of posttranslational modifications, such as phosphorylation events, in the modulation of protein-protein
interactions. To obtain a read-out of relative binding levels, 98 individually purified PDZ-domains
that had demonstrated peptide binding activity to PDZ binding motifs (Stiffler et al. 2006), from 68
different human proteins, were arrayed by the MDACC Protein Array and Analysis core facility
(Director: Mark T. Bedford, Ph.D.), and probed with biotinylated unphosphorylated versus
phosphorylated delta-catenin peptides inclusive of its PDZ-binding motif (Figure 6A). The data
pointed to a number of interactions, including positive controls that had been expected (e.g. Erbin
and Magi2; (Ide et al. 1999; Arikkath et al. 2008a)). Given my interest in potential phosphoregulation of delta’s PDZ-binding motif, I focused upon a novel pair of phospho-regulated
interactions that were revealed, namely with a PDZ-domain present in Magi1, and another in
Pdlim5, both of which are expressed in the mammalian central nervous system (Karlsson et al. 2012;
Kato et al. 2005). Using the PDZ-domain microarrays, it was found that the unphosphorylated probe
inclusive of delta’s PDZ-binding motif bound to the final PDZ domain (PDZ5) of Magi1 (pair of circled
green spots), whereas the phosphorylated probe lost most such association. These results are
consistent with earlier experiments performed by the McCrea Lab using yeast two hybrid screens
with delta-catenin as bait against a rat brain cDNA library. Two independent clones of Magi1
containing the same PDZ5 domain were identified as potential interaction partners of delta-catenin
(screen performed by Hybrigenics Inc.; results not shown). Importantly, the PDZ-domain microarrays
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revealed the opposite phospho-dependent behavior for the lone PDZ domain present within Pdlim5
(Figure 6B). While several other proteins displayed PDZ domains able to bind delta’s phosphorylated
PDZ-binding motif in vitro (e.g. Erbin), Pdlim5 was the only target observed to require the PDZbinding motif of delta-catenin to be phosphorylated in order for an interaction to occur.

To assess the independent importance of each of the phosphorylation sites in delta-catenin’s PDZbinding motif (-6 and -3 serines) for the interaction with Pdlim5, the PDZ-domain microarray was
repeated using peptides phosphorylated at only one of the two serines present. I found that deltacatenin’s PDZ-binding motif binds best to Pdlim5 when both the -6 and -3 serines of delta are
phosphorylated, although phosphorylation of even a single serine in this motif promotes this
interaction (white paired spots indicate higher association that green) (Figure 6C). Likewise,
phosphorylation at either the -6 or -3 serine interrupts any potential interaction with Magi1. This
switch-like modulation of associations with neural interaction partners hinted that delta-catenin
possesses a phospho-dependent switch, which might be relevant in the context of neuron dendrite
development.
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A

B

A: Erbin PDZ
B: Lrrc7 PDZ
C: Interleukin 16 PDZ (1/4)
D: Magi2 PDZ (6/6)

E: OMP25 PDZ
F: NHERF-2 PDZ
G: PTP-BL PDZ (2/5)

C
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H: SAP102 PDZ (2/3)
I: ZO-1 PDZ (1/3)
J: SLIM PDZ

Figure 6. Protein domain microarray reveals that delta-catenin interacts with Magi1 and Pdlim5 in a
phospho-dependent manner. (Data collected by and used with the permission of Mark T. Bedford,
PhD and Cari Sagum - MD Anderson Cancer Center)

A, Schematic of a protein-domain microarray. A comprehensive library of PDZ domain peptides on a
microplate were probed with either phosphorylated or unphosphorylated biotinylated delta-catenin
PDZ-binding motif peptides. B, Phosphorylation of the PDZ-binding motif of delta-catenin modulates
the protein’s ability to interact with several partner proteins. Magi1 is bound by the
unphosphorylated motif, but not by the phosphorylated motif (blue). Pdlim5 is only bound by the
phosphorylated delta-catenin PDZ-binding motif (red). C, Phosphorylation at either serine in the
PDZ-binding motif of delta-catenin is sufficient to allow interaction with Pdlim5. Phosphorylation at
both sites results in a more efficacious binding of Pdlim5 by delta-catenin.
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Validation of Protein Domain Microarray results:
The phospho-dependency of these interactions was further validated in cells using a method I
developed to visualize protein-protein associations within intact cells and refer to as the Golgi CoRelocalization Assay (GRA). GRA relies on relocalizing a protein of interest, in this case delta-catenin,
to the outer membrane surface of the Golgi, enabling one to see if putative partner proteins
become co-relocalized, indicating an association between the two proteins. I found traditional
protein interaction detection methods, such as co-immunoprecipitation, to be inconsistent in
detecting these PDZ domain-dependent interactions. After learning of similar issues in other labs,
including those who study validated PDZ domain-dependent interactions with delta-catenin, it
seemed that cell lysis disrupting these associations was the most likely culprit. Since GLA avoids the
harsh conditions of cell lysis, the assay is much better suited to detect weak or transient
interactions, such as those studied in this work. The GLA assay I developed was able to more
consistently detect published PDZ domain-dependent interactions (Example: delta-catenin:Magi2
(Ide et al. 1999)) than traditional methods, such as co-immunoprecipitation, and therefore became
the method of choice for observing these interactions for the remainder of this work.

To probe both the phospho- and phospho-null states of the PDZ-binding motif of delta-catenin, I
utilized point mutants in which both of delta-catenin’s -6 and -3 serines (mouse S1242, S1245) were
replaced either with glutamate (phospho-mimic) or with alanine (phospho-null). Using HEK293 cells,
which lack endogenous delta-catenin, exogenous phospho-null or phospho-mimic delta-catenin was
expressed and directed to the Golgi. When expressing phospho-null delta-catenin, I observed that
co-expressed Magi1 co-relocalized to the Golgi from the cell cytosol and membrane (Figure 7). This
same phospho-null delta-catenin construct failed to co-relocalize co-expressed Pdlim5, which
remained in the cytosol and at the cell membrane (Figure 8). Conversely, when a phospho-mimic
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delta-catenin was directed to the Golgi, Magi1 failed to co-relocalize, whereas Pdlim5 succeeded in
co-relocalizing to the Golgi with delta-catenin, indicating the presence of an interaction. Thus, my incell GRA findings support the same binding selectivity suggested from the in vitro protein-domain
microarrays. They also provide some confidence, in combination with later findings, that these
delta-catenin point mutants adequately mimic the phosphorylated versus dephosphorylated forms
of delta’s PDZ-binding motif in the context of protein binding behavior.

I also opted to further validate the results of the protein domain microarray, which suggest that
delta-catenin specifically binds the PDZ5 domain of Magi1 and the sole PDZ domain of Pdlim5. This
was accomplished by mapping the regions of Magi1 and Pdlim5 required to bind delta-catenin, via a
series of deletions within each protein, and using my Golgi Co-relocalization Assay as a readout
(Figure 9 and 10). As expected, my findings further supported the microarray results, since the sole
PDZ domain of Pdlim5, as well as the PDZ5 domain of Magi1, were required for the respective
interaction and co-relocalization of Pdlim5 and Magi1 with delta-catenin. Interestingly, deletion of
the PDZ domain of Pdlim5 induced nuclear translocation of the protein, although the significance of
this observation as not yet been elaborated upon (Figure 10B).
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Figure 7. Validation of phospho-dependency for Magi1:delta-catenin interaction via Golgi Corelocalization assay.

Mutant delta-catenin constructs (red) with phospho-null properties (S1242A, S1245A) or phosphomimic properties (S1242E, S1245E) were expressed in HEK293 cells and relocalized to the Golgi
body. Magi1 (green) co-relocalizes to the Golgi with phospho-null delta-catenin but not phosphomimic delta-catenin (red), indicating an interaction specificity for unphosphorylated delta-catenin.
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Figure 8. Validation of phospho-dependency for Pdlim5:delta-catenin interaction via Golgi Corelocalization assay.

Mutant delta-catenin constructs (red) with phospho-null properties (S1242A, S1245A) or phosphomimic properties (S1242E, S1245E) were expressed in HEK293 cells and relocalized to the Golgi
body. Pdlim5 (green) co-relocalizes to the Golgi with phospho-mimic delta-catenin but not phosphonull delta-catenin (red), indicating an interaction specificity for unphosphorylated delta-catenin,
indicating that the protein specifically interacts with phosphorylated (-3 and -6 serines) deltacatenin.
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Figure 9. Delta-catenin interacts with the c-terminal PDZ domain of Magi1.

The protein-domain microarray data was further validated using domain mapping of Magi1 in
combination with a Golgi Co-relocalization assay in HEK293 cells. A-D, Mapping of PDZ domain(s) of
Magi1 required for interaction with delta-catenin. A, Full-length Magi1 (green) co-relocalizes with
delta-catenin (red) to Golgi body. B, Deletion of PDZ4 and PDZ5 of Magi1 renders the protein unable
to interact with delta-catenin, thereby preventing co-relocalization of Magi1 with delta-catenin (red)
to the Golgi body. C, Deletion of only PDZ5 of Magi1 also renders Magi1 (green) unable to corelocalize to the Golgi, suggesting that PDZ5 is required for Magi1’s interaction with delta-catenin.
D, Expression of only PDZ4 and PDZ5 of Magi1 (green) successfully co-relocalizes to the Golgi with
delta-catenin (red).
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Figure 10. Delta-catenin interacts with the sole PDZ domain of Pdlim5.

The protein-domain microarray data was further validated using domain mapping of Pdlim5 in
combination with a Golgi Co-relocalization assay in HEK293 cells. A-B, Validation and mapping of
Pdlim5:delta-catenin interaction. A, Full-length Pdlim5 co-relocalizes with delta-catenin to Golgi
body. B, Deletion of the PDZ domain in Pdlim5 renders the protein unable to interact and corelocalize with delta-catenin.
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Part Two: Characterization of delta-catenin, Magi1 and Pdlim5 in neuron development

Spatial and temporal expression of delta-catenin, Magi1, and Pdlim5 in hippocampal neurons:
Based on available data, I was aware that delta-catenin, Magi1, and Pdlim5 are each expressed in
the mammalian central nervous system, however, a more detailed analysis of the expression pattern
of these proteins in developing neurons was needed (Ito et al. 2012; Ren et al. 2015). Through the
use of confocal microscopy, I observed that delta-catenin, Magi1, and Pdlim5 are each expressed in
hippocampal neurons during dendrite development.

I employed a rat primary hippocampal neuron culture model, as it is established in studies of
mammalian neuron development (Dotti, Sullivan, and Banker 1988; Kaech and Banker 2006). Early
in neuron development (1DIV), delta-catenin, Pdlim5, and Magi1 are expressed comparable levels,
with the amount of Magi1 relative to delta-catenin and Pdlim5 decreasing significantly as neurons
mature (28DIV). At 1DIV (days in vitro), delta-catenin is ubiquitously expressed in hippocampal
neurons. Magi1 appeared to be enriched in the soma of these neurons, with expression extending
into the bases of newly forming neurites (future dendrites). Conversely, at 1DIV, Pdlim5 is expressed
primarily in these protrusions and is enriched at their tips (Figure 11). By 7DIV, delta-catenin
continues to be ubiquitously expressed, with Magi1 and Pdlim5 having enriched localization to the
dendrites. Specifically, at 7DIV, Magi1 protein appears to be highly enriched at the tips of dendrites,
with lower amounts present elsewhere in dendrites and soma. Pdlim5 is also present in the soma
but enriched in dendrites, with the highest visualization in dendrite tips. In mature hippocampal
neurons (28DIV), both delta-catenin and Pdlim5 protein are still present in dendrites, whereas
Magi1 expression/localization is lessened, in line with reduced dendrite extension by this point in
development. The coordinate presence of delta-catenin, Magi1, and Pdlim5 throughout much of
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hippocampal in vitro development, and my resolution of the delta:Magi1 and delta:Pdlim5 protein
complexes (see also below), supports the potential contribution of these interactions to
dendritogenesis.

Through the use of super-resolution confocal microscopy (STORM), I found that both Magi1 (Figure
12) and Pdlim5 (Figure 13) localize to punctated and potentially distinct filopodial-like structures
along dendrites of hippocampal neurons (4DIV). Via STORM, delta-catenin appears at the base of
these delta:Magi1 and delta:Pdlim5 structures, as well as within the lengths of dendrites. While both
the Magi1 and Pdlim5 enriched structures occur along the length of dendrites, the Magi1 intensities
appear more evident towards dendritic tips (White arrows, Figure 12). Given the potential detail
that can be revealed with STORM imaging, a separate study will be needed to fully examine the
delta:Magi1 and delta:Pdlim5 complexes in relationship to cytoskeletal and other associated
proteins. Additionally, further examination of the properties of these filopodia-like structures will be
required to fully discern their roles in the biology of neurons. Nevertheless, my findings from STORM
imaging of hippocampal neurons continue to support a role for delta-catenin, Magi1, and Pdlim5 in
dendrite development.
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Figure 11. Distribution of delta-catenin, Magi1, and Pdlim5 during hippocampal neuron
development.

Expression of delta-catenin (green), Magi1 (red-top), and Pdlim5 (red-bottom) in developing primary
rat hippocampal neurons at 1DIV, 7DIV, and 28DIV. Delta-catenin (green) is ubiquitously expressed
in hippocampal neurons throughout development. Magi1 (red-top) localizes to neurite extensions
by 1DIV (top-left) and becomes further enriched at dendritic tips at 7DIV (top-center). Magi1
expression becomes reduced by the time of neuronal maturation at 28DIV, though is still present in
the dendrites and soma (top-right). Pdlim5 (red-bottom) localizes to neurite protrusions as early as
1DIV (bottom-left), and becomes highly enriched near the dendritic tips by 7DIV (bottom-center).
Pdlim5 remains enriched in the axon/dendrites through neuronal maturity at 28DIV (bottom-right).
Scale bars indicate 20μm.
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Figure 12. Magi1 localizes to puncta near the tips of developing dendrites.

Super-resolution imaging (STORM) of Magi1 (green) and delta-catenin (red) reveals that Magi1
localizes in a punctated manner to the tips of dendrites in filopodia-like structures (white arrows),
while delta-catenin is mostly ubiquitously expressed along the dendrite, though becomes enriched
near the Magi1 puncta in several cases.
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Figure 13. Pdlim5 localizes to puncta along the length of developing dendrites.

Super-resolution imaging (STORM) of Pdlim5 (green) and delta-catenin (red) shows that Pdlim5
localizes along the length of dendrites to filipodia-like structures, while delta-catenin appears to
localize towards the base of these structures (as well as along the length of the dendrite).
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Delta-catenin interacts with Magi1 and Pdlim5 during hippocampal neuron development:
To assess whether endogenous delta-catenin interacts in primary rat hippocampal neurons with
endogenous Magi1 and Pdlim5, I utilized a proximity ligation assay (PLA) (Duolink). This method
detects direct or closely apposing interactions (Söderberg et al. 2006). I opted to use PLA to further
validate the existence of these interactions for two primary reasons. First, my Golgi co-relocalization
assay relies on the exogenous expression of proteins in established cell lines, whereas PLA can
detect interactions between endogenous proteins, without the need to lyse cells, as required in the
case of co-immunoprecipitation, which can also detect interactions between endogenous proteins.
Second, PLA has the ability to reveal direct interactions in primary neuronal cultures, a key
observation required to establish the significance of protein complexes in neuron development and
function.

At 7DIV, hippocampal cultures exhibited significantly more PLA puncta for the delta-catenin:Magi1
and delta-catenin:Pdlim5 complexes than in negative controls (delta-catenin:c-Jun) (Figure 14).
Puncta were substantially localized along dendrites, supporting the presence of these complexes in
developing neurons. It is worth noting that it is difficult to extract information on precise localization
of protein complexes using PLA, and the method is best suited for the detection of direct
interactions and the general localization of such associations. Regardless, my PLA findings in
common with STORM observations support delta-catenin’s direct endogenous interactions with
Magi1 and Pdlim5 in dendrites, consistent with functional relationships as revealed below.

56

A

B

Figure 14. Delta-catenin interacts with endogenous Magi1 and Pdlim5 in hippocampal neurons.

Detection of direct associations between delta-catenin and the proteins Magi1 and Pdlim5 in
developing hippocampal neurons. A Proximity Ligation Assay (Duolink), in combination with deltacatenin, Magi1, and Pdlim5 antibodies, was used to detect direct protein-protein interactions in
7DIV hippocampal neurons. A, Visualization of Magi1:delta-catenin (left) and Pdlim5:delta-catenin
(center) interactions, as detected by the presence of red puncta. Antibodies specific to delta-catenin
and c-Jun were used in a negative control assay (right). B, Quantification of average puncta per
neuron in each condition (delta-catenin+ Magi1: 16.01 (p=0.0159); Pdlim5: 37.73 (p=0.0007); cJun/Control: 2.393; n=3 independent experiments).
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Delta-catenin contributes to the in vitro morphogenesis of hippocampal neurons:
Given the reported roles of delta-catenin in neuronal development and dendrite morphology, I
aimed to address mechanisms by which this protein functions in neurons. To address the neuronal
roles of delta-catenin, a primary rat hippocampal neuron culture model was used. Primary rat
hippocampal neurons were transfected at 3 days in vitro (DIV) and fixed at 7DIV. The rationale for
choosing 7DIV as my assay stop-point is that at 7DIV the dendritic tree is already quite complex, yet
very few synapses have started to form. This enabled me to address impacts on dendrite
morphology prior to synaptic changes becoming an additional driving force behind observed
alterations. However, given the roles of these proteins described in this work, all three may very
well function in synaptogenesis, synaptic maintenance, and post-developmental dendritic
maintenance. Therefore, it will be very interesting to study the roles of delta-catenin, Magi1, and
Pdlim5 beyond early dendrite development, as they may likely contribute to neuronal connectivity
via multiple interconnected mechanisms, in addition to those described in this work.

In developing neurons experiencing shRNA-mediated knockdown of delta-catenin beginning at 3DIV
(using a previously published delta-catenin shRNA sequence (Arikkath et al. 2008a)), the dendritic
tree was much more restricted when compared to control neurons at 7DIV (Figure 15). Validation of
shRNA-mediated knockdown of delta-catenin revealed a near complete loss of delta-catentin in
HEK293 cells (Figure 16). While dendrite lengths were significantly reduced, the overall number of
dendrites was left relatively unchanged, suggesting that delta-catenin may not be essential for early
dendritogenesis, but rather dendritic tree elaboration (extension/branching of existing dendrites).
Conversely, when delta-catenin was exogenously overexpressed (initiated at 3DIV), dendritic trees
showed significant increases in complexity as well as length compared to controls by 7DIV (Figure
15). These overexpression findings support the notion that expression of delta-catenin is sufficient
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to drive the elaboration of dendritic arborizations in developing neurons. Together, these results
(knockdown and overexpression of delta-catenin) support prior studies that dendrite branching and
elongation is modulated by delta-catenin (Arikkath et al. 2008b; Martinez et al. 2003).

Magi1 contributes to dendrite extension during neuronal development:
I next sought to elaborate on the known neuronal functions of Magi1, and utilized the same primary
neuron culture model as previously described for the work on delta-catenin. Neurons
overexpressing Magi1 developed significantly longer dendrites when compared to controls, whereas
dendrite density (number of tips) was not significantly changed (Figure 17). In addition to
overexpression of Magi1, I utilized shRNA-mediated knockdowns beginning at 3DIV with fixation
done at 7DIV. This allowed me to observe how dendrites develop with reduced levels of Magi1.
Unlike with delta-catenin, a previously published shRNA sequence targeting Magi1 did not exist. In
order to knockdown Magi1 in neurons, I screened several predicted hairpin sequences capable of
preventing Magi1 translation in neurons using the siRNA Wizard v3.1 tool (InvivoGen), and validated
the knockdown efficiency of these sequences until one was observed to produce a sufficient
knockdown of Magi1 in HEK293 cells (Figure 18). All sequences generated were compared to rat,
mouse, and human Magi1 in order to produce a single shRNA sequence hopefully capable of
knocking down protein expression in cells from each of these organisms. Consistent with my overexpression results, knock-down of Magi1 in developing hippocampal neurons significantly decreased
average dendrite lengths (Figure 17B). Interestingly, similar to overexpression of Magi1, neurons
exhibiting reduces levels of the protein did not have significant changes in overall dendrite density.
These results suggest that Magi1 plays a role in dendrite elongation rather than dendrite branching
during neuronal development.
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Figure 15. Delta-catenin plays a major role in the establishment of hippocampal neuron dendrite
morphology.

Primary rat hippocampal cultures were transfected at 3DIV and imaged at 7DIV to quantify dendritic
morphology. A, representative images of 7DIV rat hippocampal neurons expressing GFP, deltacatenin cDNA, and delta-catenin shRNA. B, Quantification of average dendrite length of neurons
expressing GFP (35.96 ± 1.56 μm), delta-catenin cDNA (49.14 ± 1.72 μm; p < 0.0001), and deltacatenin shRNA (24.98 ± 1.13 μm; p < 0.0001). C, Average dendrite density of neurons expressing GFP
(16.69 ± 1.26), delta-catenin cDNA (30.90 ± 2.03; p < 0.0001), and delta-catenin shRNA (14.56 ± 1.43;
p < 0.0001). D, Sholl analysis of dendrite morphology for control, delta-catenin overexpressing, and
delta-catenin shRNA-expressing neurons. Relative to GFP-expressing cells, neurons overexpressing
delta-catenin possessed significantly more dendrites at 25μm to 70μm from the soma (p ≤ 0.0001)
and from 70μm to 110μm from the soma (p < 0.05). *** p ≤ 0.0001. Error bars indicate SEM. For B,
C, n ≥ 12 neurons, for D, n = 6. Scale bars indicate 20μm.
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Figure 16. Validation of shRNA-mediated knockdown of delta-catenin.

HEK293 cells were treated with a previously published shRNA targeting delta-catenin. At 48hrs posttransfection, no delta-catenin was detected via Western blotting. HEK293 cells represent an
acceptable system to test shRNA in as these cells transfect readily (unlike primary neurons) and are
believed to be potentially of neural origin due to their numerous neuronal properties.
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Figure 17. Magi1 expression contributes to and is required for dendrite elongation.

Primary rat hippocampal neurons were transfected at 3DIV and imaged at 7DIV to quantify dendritic
morphology. A, Representative images of 7DIV rat hippocampal neurons transfected with GFP
(Control), Magi1 cDNA, or Magi1 shRNA. B, Quantification of average dendrite length of neurons
expressing GFP (35.96 ± 1.56 μm), Magi1 cDNA (60.98±2.69 μm; p<0.0001), and Magi1 shRNA
(21.72±0.98; p<0.0001). C, Average dendrite density was not significantly affected by expression of
Magi1 cDNA (20.5±1.04; p=0.132) or Magi1 shRNA (17.92±2.01; p=0.785) when compared to GFP
controls (16.69±1.26). D, Sholl analysis of dendrite morphology for control, Magi1 overexpressing,
and Magi1 shRNA-expressing neurons. Relative to GFP-expressing cells, neurons overexpressing
Magi1 possessed significantly more dendrites at 35μm to 130μm from the soma (p < 0.05),
indicating the presence of longer dendrites. Conversely, neurons subjected to shRNA-mediated
knockdown of Magi1 developed significantly fewer dendrites at 15μm and 30μm to 40μm (p < 0.05).
*** p ≤ 0.0001. Error bars indicate SEM. For all conditions in A-C n ≥ 12 neurons, for D, n = 6. Scale
bars indicate 20μm.
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Figure 18. Validation of shRNA-mediated knockdown of Magi1.

HEK293 cells were treated with shRNA targeting human/mouse/rat Magi1. At 48hrs posttransfection, a significant knockdown of Magi1 was observed via Western blotting. The shRNA
produced an approximate 68% reduction in Magi1 protein levels.
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Pdlim5 contributes to dendrite branching during neuronal development:
In order to elucidate the roles of Pdlim5 in dendrite development, I employed the same techniques
as with delta-catenin and Magi1. At 7DIV, neurons overexpressing Pdlim5 developed dendrites with
similar lengths as controls, yet with significant increases in dendritic tree density, as measured by
sholl analysis and by number of dendritic tips (Figure 19). In order to observe how the dendrites of
the neurons develop in the presence of reduced levels of Pdlim5, I utilized shRNA-mediated
knockdown of Pdlim5. As was the case with Magi1, a previously published shRNA sequence
targeting Pdlim5 did not exist prior to this work. I utilized the same methods described with Magi1
to generate a Pdlim5 shRNA sequence capable of knocking down expression of the protein in rat,
mouse, and human cells, and validated this knockdown in HEK293 cells (Figure 20). Unfortunately,
the best candidate sequence screened only produced a roughly 40% knockdown of Pdlim5 protein
levels (quantified using densitometry of western blots), though even at this level, a phenotype was
observed in hippocampal neurons.

Surprisingly, when neurons were knocked-down for Pdlim5, rather than fewer dendrites as had
been anticipated, longer dendrites formed. This suggests that in addition to promoting branching
activity in developing dendrites, Pdlim5 may participate in the inhibition of dendritic elongation. I
wish to remind the reader that the shRNA-mediated knockdown of Pdlim5 was not complete (~40%
reduction), and thus more complete depletion might produce an effect on dendrite numbers. In any
case, my current data suggest some cross-talk between the ascribed activities of Pdlim5 (branching)
and Magi1 (lengthening) during dendrite development, and that Pdlim5 may exercise more limited
roles in early neurite formation when compared to its roles in dendrite elaboration (Figure 19).
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Figure 19. Pdlim5 expression contributes to dendrite branching and restriction of outgrowth.

Primary rat hippocampal neurons were transfected at 3DIV and imaged at 7DIV to quantify dendritic
morphology. A, Representative images of 7DIV rat hippocampal neurons transfected with GFP
(Control), Pdlim5 cDNA, or Pdlim5 shRNA. B, Quantification of average dendrite length of neurons
expressing GFP (35.96 ± 1.56 μm), Pdlim5 cDNA (35.69 ± 1.01 μm; p=0.9916) and Pdlim5 shRNA
(53.25 ± 2.99 μm; p<0.0001). C, Average dendrite density of neurons expressing GFP (16.69 ± 1.26),
Pdlim5 cDNA (38.13 ± 3.06; p<0.0001), and Pdlim5 shRNA (16.33 ± 1.61; p<0.0001). D, Sholl analysis
of dendrite morphology for control, Pdlim5 overexpressing, and Pdlim5 shRNA-expressing neurons.
Relative to GFP-expressing cells, neurons overexpressing Pdlim5 possessed significantly more
dendrites at 15μm to 40μm from the soma (p ≤ 0.0001). Conversely, neurons subjected to shRNAmediated knockdown of Pdlim5 developed significantly more dendrites at 35μm to 95μm (p < 0.05),
indicating the presence of longer dendrites. *** p ≤ 0.0001. Error bars indicate SEM. For all
conditions in A-C n ≥ 12 neurons, for D, n = 6. Scale bars indicate 20μm.
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Figure 20. Validation of shRNA-mediated knockdown of Pdlim5

HEK293 cells were treated with shRNA targeting human/mouse/rat Pdlim5. At 48hrs posttransfection, a significant knockdown of Pdlim5 was observed via Western blotting. The shRNA
produced an approximate 40% reduction in Pdlim5 protein levels. While this relatively inefficient
knockdown of Pdlim5 was sufficient to produce a phenotype in neurons, further study of Pdlim5
using a more complete knockdown of the protein may reveal additional roles of the protein in
neuronal development.
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Part Three: Identification of the significance of the phosphorylation state of delta-catenin and
subsequent interactions with Magi1 and Pdlim5 in dendrite development

Generation of Magi1 and Pdlim5 mutants incapable of binding delta-catenin:
Given the overlapping roles of Magi1 and Pdlim5 with delta-catenin in dendrite development, and
the complimentary nature of these roles (branching versus elongation), I wished to determine if
these functions were dependent upon an interaction with delta-catenin. This required the
generation of loss-of-function/interaction mutants of Magi1 and Pdlim5 that were incapable of
binding delta-catenin. To enable me to create these loss-of-function constructs of Magi1 and
Pdlim5, and with the help of Xiaojiang Chen, Ph.D. (University of Southern California), we identified
residues in the respective PDZ domains of Magi1 and Pdlim5 required to bind the dephospho versus
phospho PDZ-binding motif of delta-catenin. Based on solved crystal structures of similar complexes
as well as computational modeling via threading and docking simulation (see Methods), I was able
to view, at atomic resolution, predicted interactions of the PDZ5 domain of Magi1, or the sole PDZ
domain Pdlim5, with the PDZ-binding-motif of delta-catenin. Using this information, I generated
double-point mutants of Magi1 (H62A, I66Y) and Pdlim5 (H63A, Q67Y), respectively, expected to be
incapable of binding to the dephospho versus phospho (-6 & -3 serines) form of delta-catenin’s PDZbinding motif (Figure 21). I named these double-point mutants Magi1-H62A/I66Y and Pdlim5H63A/Q67Y, after the respective mutations in each protein. The loss of these mutants’ ability to
bind delta-catenin’s PDZ-ligand was confirmed in HEK 293 cells by using the GRA. Unlike their
respective wild-type proteins, both Magi1-H62A/I66Y and Pdlim5-H63A/Q67Y failed to ectopically
co-relocalize with delta-catenin directed to the Golgi, suggesting that an interaction between these
proteins and delta-catenin did not occur (Figure 22).
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Figure 21. Computational modeling of delta-catenin:Magi1 and delta-catenin:Pdlim5 interactions.
(Data collected by and used with the permission of Xiaojiang Chen, Ph.D. and Aaron Wolfe University of Southern California)

A, Amino Protein sequences of Human Magi1 PDZ5 and Mouse Pdlim5 PDZ. Residues mutated to
prevent interaction with delta-catenin are highlighted in red (Magi1: H62A/I66Y; Pdlim5:
H63A/Q67Y). B, Amino acid schematic of a general PDZ-binding motif and delta-catenin’s PDZ
binding motif, showing serines at -3 and -6 locations. C-D, Models of the Magi1:delta-catenin (C) and
Pdlim5:delta-catenin (D) interactions.
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Figure 22. Magi1 and Pdlim5 mutants fail to interact with delta-catenin.

Validation of lack of interaction between mutant Pdlim5 and Magi1 with delta-catenin via a Golgi
Co-relocalization assay in HEK293 cells. A, WT Pdlim5 (green-top) co-relocalizes with delta-catenin
(red) to the Golgi, while Pdlim5 - H63A/Q67Y (green-bottom) fails to co-relocalize to the Golgi with
delta-catenin (red). B, WT Magi1 (green-top) co-relocalizes with delta-catenin (red) to the Golgi,
while Magi1 - H62A/I66Y (green-bottom) fails to co-relocalize to the Golgi with delta-catenin (red).
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Magi1 and Pdlim5 require interaction with delta-catenin to execute roles in dendrites:
I then asked if the loss of Magi1’s or Pdlim5’s ability to bind delta-catenin altered its respective
expression-phenotype in hippocampal neurons. Mutant constructs were overexpressed in primary
rat hippocampal neurons starting at 3DIV, with fixation occurring at 7DIV. Dendrite length and
density were then measured and compared to wild-type Magi1/Pdlim5 overexpression as well as to
GFP controls. Interestingly, exogenous Magi1-H62A/I66Y overexpression exhibited considerably less
impact upon dendrite length at 7DIV when compared to wild-type Magi1 overexpression, and failed
to induce dendrite elongation (Figure 23). This suggests that the role of Magi1 in dendrite
development may be mostly dependent on an interaction with delta-catenin’s PDZ-binding motif.
Likewise, neurons overexpressing exogenous Pdlim5-H63A/Q67Y showed a reduced impact upon
dendritic tree density relative to neurons expressing exogenous wild-type Pdlim5 (Figure 24). While
Pdlim5-H63A/Q67Y-expressing neurons did develop denser dendritic trees than GFP controls, their
resulting reduction in dendrite density relative to wild-type Pdlim5 overexpression is consistent with
Pdlim5’s role in dendritic branching being partially dependent on its ability to interact with deltacatenin. Taken together, my findings from the Magi1 and Pdlim5 point mutants further support the
notion that each protein interacts with delta-catenin as part of mechanistic pathways pertinent to
the establishment of dendrite morphology in hippocampal neurons.
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Figure 23. Magi1 expression fails to induce dendrite extension in absence of delta-catenin
interaction.

A, Representative images of 7DIV primary rat hippocampal neurons expressing Magi1 cDNA and
Magi1 - H62A/I66Y cDNA. B, Quantification of average dendrite length of neurons expressing GFP
(35.96 ± 1.56 μm), Magi1 cDNA (60.98±2.69 μm; p<0.0001), and Magi1 - H62A/I66Y cDNA
(36.97±1.86 μm; p=0.997). Overexpression of Magi1 - H62A/I66Y failed to induce the dendrite
extension that results from native Magi1 overexpression (p ≤ 0.0001). C, Average dendrite density of
neurons expressing GFP (16.69±1.26), Magi1 cDNA (20.50±1.04; p=0.0.690) and Magi1 - H62A/I66Y
cDNA (19.4±2.06; p=0.914). D, Sholl analysis of dendrite morphology for GFP control, Magi1
overexpressing, and Magi1 mutant (H62A/I66Y) overexpressing neurons. Relative to overexpression
of native Magi1, neurons overexpressing Magi1 - H62A/I66Y possessed significantly fewer dendrites
at 40μm (p = 0.0090) and 60μm from the soma (p = 0.0357). Overexpression of Magi1 - H62A/I66Y
produced no changes in dendrite length/density relative to GFP controls. *** p ≤ 0.0001, * p ≤ 0.05.
Error bars indicate SEM. For all conditions in A-C, n ≥ 12 neurons, in D, n = 6. Scale bars indicate
20μm.
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Figure 24. Impact of Pdlim5 expression on dendrite branching weakens in absence of delta-catenin
interaction.

A, Representative images of 7DIV primary rat hippocampal neurons expressing Pdlim5 cDNA and
Pdlim5 - H63A/Q67Y cDNA. B, Quantification of average dendrite length of neurons expressing GFP
(35.96 ± 1.56 μm), Pdlim5 cDNA (35.69 ± 1.01 μm; p=0.9916), and Pdlim5 - H63A/Q67Y cDNA
(38.63±1.85 μm; p=0.873). C, Average dendrite density of neurons expressing GFP (16.69±1.26),
Pdlim5 cDNA (38.13 ± 3.06; p<0.0001), Pdlim5 - H63A/Q67Y cDNA (25.70±2.32; p=0.0491). Neurons
overexpressing Pdlim5 - H63A/Q67Y failed to increase dendrite density to the extent of native
Pdlim5 overexpression (p=0.0016). D, Sholl analysis of dendrite morphology for GFP control, Pdlim5
overexpressing, and Pdlim5 mutant (H63A/Q67Y) overexpressing neurons. Relative to GFPexpressing cells, neurons overexpressing Pdlim5 - H63A/Q67Y possessed significantly more
dendrites at 40μm (p = 0.0315) and 50μm from the soma (p = 0.0333). Relative to neurons
overexpressing native Pdlim5, neurons overexpressing Pdlim5 - H63A/Q67Y developed significantly
fewer dendrites at 15µm to 25µm from the soma (p < 0.05). *** p ≤ 0.0001, * p ≤ 0.05. Error bars
indicate SEM. For all conditions in A-C, n ≥ 12 neurons, in D, n = 6. Scale bars indicate 20μm.
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Phosphorylation of the PDZ-binding motif of delta-catenin modulates dendritic morphology.
To better address the functional role of the phosphorylation sites within the PDZ-binding motif of
delta-catenin, I used my previously described phospho-mutants of delta-catenin. Specifically, the -6
and -3 position residues in delta-catenin (mouse S1245 and S1242), were mutated to alanine
(phospho-null) or glutamate (phospho-mimic). To investigate the impact of these mutants on
dendrite development, I expressed them in developing primary rat hippocampal neuron cultures,
beginning at 3DIV. Upon fixation and imaging at 7DIV, hippocampal neurons expressing phosphonull delta-catenin – which preferentially binds Magi1 – developed significantly longer dendrites, with
little-to-no change in the number of dendrites per neuron when compared to controls (Figure 25).
This observed morphology was strikingly similar to that following Magi1 overexpression. Conversely,
when a phospho-mimic delta-catenin was expressed – which preferentially binds Pdlim5 – neurons
developed strikingly dense dendritic trees relative to controls, with little effect upon dendrite length
(Figure 25). Thus, the expression of the phospho-mimic of delta-catenin produced similar
phenotypes as overexpressing Pdlim5, further supporting a related role of these proteins in dendrite
development. Interestingly, I found both the phospho-null delta-catenin and phospho-mimic deltacatenin mutants to be extremely toxic to the neurons expressing them. This suggests that
phosphorylation of delta-catenin is a tightly regulated process underlying key neuronal functions, as
native delta-catenin (which can be phosphorylated/dephosphorylated in neurons) overexpression
exhibits no such toxicity. Nonetheless, these data remain consistent with the idea that
phosphorylation of delta-catenin’s PDZ-binding motif constitutes a phospho-switch that assists in
determining dendrite morphology, and that this switch is likely to be related to differentially forming
interactions with either Magi1 or Pdlim5.

78

A

B

C

D

79

Figure 25. Phosphorylation of the PDZ-binding motif of delta-catenin modulates its role in dendrite
development.

A, Representative images of 7DIV rat hippocampal neurons transfected with GFP (Control), deltacatenin cDNA, delta-catenin-EE (phospho-mimic) cDNA, and delta-catenin-AA (phospho-null) cDNA.
B, Quantification of average dendrite length of neurons expressing vector (35.96 ± 1.56 μm), deltacatenin cDNA (49.14 ± 1.72 μm; p < 0.0001), delta-catenin-EE (phospho-mimic) cDNA (33.59±0.90
μm; p=0.601), and delta-catenin-AA (phospho-null) cDNA (61.50±2.286 μm; p<0.0001). C, Average
dendrite density of neurons expressing vector (16.69 ± 1.26), delta-catenin cDNA (30.90 ± 2.03;
p<0.0001), delta-catenin-EE (phospho-mimic) cDNA (34.00±2.65; p<0.0001), and delta-catenin-AA
(phospho-null) cDNA (20.00±1.96; p=0.601). D, Sholl analysis of dendrite morphology for control,
delta-catenin overexpressing, phospho-mimic delta-catenin overexpressing, and phospho-null deltacatenin overexpressing neurons. Relative to GFP-expressing cells, neurons overexpressing phosphomimic delta-catenin possessed significantly more dendrites at 15μm to 135μm from the soma (p <
0.05). Conversely, neurons overexpressing phospho-null delta-catenin developed significantly more
dendrites at 60μm to 75μm (p < 0.05), relative to GFP controls. Neurons overexpressing native deltacatenin possessed significantly more dendrites at 25μm to 70μm from the soma (p ≤ 0.0001) and
from 70μm to 110μm from the soma, relative to GFP controls (p < 0.05). *** p ≤ 0.0001. Error bars
indicate SEM. For all conditions in A-C, n ≥ 12 neurons, in D, n = 6. Scale bars indicate 20μm.
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Part Four: Identification of upstream drivers and downstream effectors of delta-catenin PDZbinding motif phosphorylation

Glutamate signaling initiates phosphorylation of delta-catenin’s PDZ-binding motif and influences
its role in dendrite development:
To assess signaling pathways upstream of the phosphorylation of delta-catenin’s PDZ-binding motif,
I utilized a combination of two primary antibodies (see Methods). One antibody was directed against
delta-catenin, while the other recognizes a phospho-MAPK/CDK consensus (PXS*P), which I
observed within the PDZ-binding motif of delta-catenin. This allowed for specific detection/
quantification of phosphorylation of delta-catenin’s PDZ-binding motif at the -6 serine position via
standard immunoprecipitation/Western Blot techniques (Figure 26). Using this combination of
antibodies, I found that, in hippocampal neuron cultures, DHPG (a Type 1 mGluR agonist) stimulated
phosphorylation of delta-catenin’s PDZ-binding motif. Following treatment (7DIV; 25μM DHPG, 15
minutes), delta-catenin was phosphorylated at levels nearly 13-fold higher than control neurons
(Figure 27). This is consistent with the possibility that metabotropic glutamate receptors are
involved in signaling upstream of phosphorylation of delta’s PDZ-binding motif. Interestingly,
stimulation with CHPG (mGluR5 agonist) also resulted in increased delta-catenin’s phosphorylation
in neuronal cultures, but to a lesser extent (not shown). Further, the increase in phosphorylation
following Type 1 mGluR activation was very short-lived, and dissipated within 1 hour of treatment.
This transient phosphorylation, combined with the noted toxicity of the mutant delta-catenin
constructs, suggests that delta-catenin may be phosphorylated only at very specific points during
neuronal development. Given these agonist-induced phosphorylation responses, Type1 mGluRs
appear to be well poised to modulate phosphorylation of delta-catenin’s PDZ-binding motif, and its
subsequent impact on dendrite morphology.
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Figure 26. Validation of specificity of detection method for phosphorylated delta-catenin.

A combination of phospho-MAPK/CDK consensus sequence and delta-catenin antibodies can
specifically detect phosphorylation of delta-catenin’s PDZ-binding motif. Western blot images of
HEK293 cells transfected with WT delta-catenin and delta-catenin-AA (phospho-null) cDNA. A
combination of CST Phospho-MAPK/CDK and Sigma delta-catenin antibodies fails to detect phosphonull delta-catenin (left).
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Figure 27. Type 1 mGluR activation is sufficient to drive phosphorylation of delta-catenin.

A, Western blots of immunoprecipitated phospho-delta-catenin from 7DIV rat hippocampal cells
following treatment with DHPG (20μM; 10 minutes) versus no treatment. B, Quantification of foldchange in delta-catenin phosphorylation following DHPG treatment in 7DIV rat hippocampal cells.
Treatment of 7DIV primary neurons with 20μM DHPG for 10 minutes resulted in a nearly 13-fold
increase (12.98±3.79) in relative levels of phosphorylated delta-catenin compared to controls (p =
0.0215).
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To determine whether DHPG-induced phosphorylation of delta-catenin’s PDZ-binding motif alters
the delta-catenin:Magi1 or delta-catenin:Pdlim5 complexes, I utilized the prior-noted Proximity
Ligation Assay (PLA) in neuronal cultures. When 3DIV neurons were subjected to DHPG treatment
(25μM; 30 minutes), the relative fraction of puncta reporting on the delta-catenin:Magi1 complex
decreased relative to controls, and conversely, puncta reporting upon the delta-catenin:Pdlim5
complex were significantly increased (Figure 28). This key experiment, assessing endogenous
protein interactions in neurons, further implicates glutamate signaling in the phospho-dependent
switch between the delta-catenin:Magi1 and delta-catenin:Pdlim5 associations during the
development of neurites/dendrites. Further, these data provide additional evidence for a
developmentally-relevant interaction between delta-catenin and the PDZ proteins Magi1 and
Pdlim5 during neuronal development that is regulated via a known modulator of dendrite
morphology (glutamate).

After observing the induced phosphorylation of delta-catenin’s PDZ-binding motif following Type 1
mGluR stimulation, I next chose to investigate whether DHPG-induced mGluR signaling (leading to
phosphorylation of delta-catenin’s PDZ-binding motif) also modulates dendrite morphogenesis.
Primary hippocampal neurons visualized via transfection with GFP at 3DIV as previously described,
were treated with DHPG at 7DIV (25μM; 180 minutes). I opted for a longer treatment window to
allow for morphological changes to occur. No morphological changes were observed after 30
minutes, despite the phosphorylation levels of delta-catenin having peaked by that time. In
agreement with published studies (Previtera and Firestein 2015a; Cruz-Martín, Crespo, and PorteraCailliau 2012), DHPG-treatment increased dendrite numbers relative to controls (Figure 29). This is
in line with the phenotypes I observed upon the expression of phospho-mimic delta-catenin
(enhanced Pdlim5 association), or expression of exogenous Pdlim5 in developing neurons.
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Figure 28. Type 1 mGluR activation is sufficient to influence endogenous delta-catenin complexes.

Quantification of puncta/cell detected by a Proximity Ligation Assay (Duolink) in 7DIV rat
hippocampal neurons. Cells were fixed immediately following treatment (no treatment vs 20μM
DHPG; 10 minutes) and subjected to the assay. DHPG treatment produced an increase in the
Pdlim5:delta-catenin complex puncta relative to no treatment (54.20±3.24 vs 20.46±1.41;
p=0.0007), while simultaneously reducing the amount of Magi1:delta-catenin complex detected per
cell relative to controls (8.95±1.59 vs 21.15±7.24; p=0.0473).
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Figure 29. DHPG stimulation induces dendritic branching in hippocampal neurons.

A, Representative images of 7DIV rat hippocampal neurons transfected with GFP and subjected to
no treatment or 20μM DHPG for 6 hours. For each condition image, representative close-ups of
dendritic branches are shown. B, Quantification of dendritic density following DHPG treatment
(23.92±1.06, p=0.0002). n ≥ 12 neurons. C, Sholl analysis of dendrite morphology for control and
DHPG-treated neurons. Neurons treated with DHPG developed significantly more dendrites than
GFP controls at 20μm to 35μm from the soma (p < 0.05), n = 6. *** p ≤ 0.0001, * p < 0.05. Scale bars
indicate 20μm.
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Lastly, I sought to identify a kinase downstream of mGluR5, responsible for phosphorylation of
delta-catenin’s PDZ-binding motif. Because the PDZ-binding motif of delta-catenin contains a
MAPK/CDK consensus, I focused on select CDK or MAPK members implicated in neuron
development (Liang et al. 2015; Cheung et al. 2007; Yamasaki, Kawasaki, and Nishina 2012). HEK293
cells were transfected with delta-catenin and either CDK5 + p35 (positive-acting factor associated
with CDK5), dnCDK5 + p35, or MKK7. I found that CDK5 + p35 produced the highest relative levels of
PDZ-binding motif phosphorylation (17-fold increase relative to controls) (Figure 30). While future
studies are needed to better delineate this pathway as well as to reveal other potential kinases
upstream of this phosphorylation event, my observations implicate CDK5 as a potential modulator
of delta-catenin’s association with Pdlim5 versus Magi1, and thereby of branching versus
lengthening dendrite morphologies.
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Figure 30. Expression of constitutively-active CDK5 increases relative levels of phospho-deltacatenin.

Representation of fold-change in levels of phosphorylated delta-catenin relative to total deltacatenin in response to exogenous co-expression of kinases in HEK293 cells. Co-expression of
constitutively-active CDK5 and p25c with delta-catenin resulted in a 17-fold increase in the relative
amount of phosphorylated delta-catenin in cell lysates.
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Delta-catenin, Magi1, and Pdlim5 may modulate dendrite extension/branching through inhibition
of RhoA:
Lastly, I considered potential effectors acting downstream of phosphorylation of delta-catenin’s
PDZ-binding-motif in dendrite development. I focused upon RhoA, since it is inhibited via deltacatenin as reported in both neuronal and non-neuronal cell types (H. Kim, Han, et al. 2008; H. Kim,
Oh, et al. 2008; D. Zhang et al. 2014). Further, RhoA inhibition is implicated in the promotion of
dendritic branching (Ay Nakayama, Harms, and Luo 2000). To compare the relative levels of active
RhoA across conditions, I utilized an ELISA-based assay (Cytoskeleton, Inc.), and cellular extracts
from HEK293 cells - since they allow facile expression of Pdlim5, Magi1, and/or delta-catenin
constructs. Additionally, given the results from my kinase experiments, and the fact that deltacatenin expression can induce the formation of protrusions in HEK293 cells (Abu-Elneel et al. 2008),
this cell line appears to have at least some of the components relevant to the delta-catenin pathway
I am studying in neurons. Relative to cells expressing wild-type delta-catenin, the delta phospho-null
mutant (S→A at -6 & -3 residue positions; mouse S1245A, S1242A), which favors binding Magi1
(over Pdlim5), produced no change in the relative levels of active RhoA. In contrast, expression of
the phospho-mimic delta-catenin (glutamate placed at -6 & -3 positions; S1245E, S1242E), which
favors binding to Pdlim5, significantly reduced the relative amount of active RhoA (Figure 31). While
the co-expression of either Magi1 or Pdlim5 with delta-catenin amplified RhoA inhibition relative to
expressing delta-catenin alone, the co-expression of Pdlim5 with delta-catenin produced the
greatest inhibition of RhoA. These observations are consistent with the possibility that the extent of
downstream-inhibition of RhoA, as influenced by distinct delta-catenin complexes (directed by the
phospho-status of delta-catenin’s PDZ-binding motif), contributes to determining outcomes of
dendrite branching versus elongation.
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Figure 31. Phosphorylation of the PDZ-binding motif of delta-catenin mediates its regulation of RhoA
activity.

Quantification of levels of active RhoA in HEK293 cells expressing WT delta-catenin (baseline),
phospho-null delta-catenin (102% of baseline), phospho-mimic delta-catenin (85% of baseline),
Magi1 + delta-catenin (88% of baseline), or Pdlim5 + delta-catenin (69% of baseline). * p < 0.05.
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Chapter III

Discussion
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My findings help to link the neural catenin-family protein, delta-catenin, to a phosphorylationdependent pathway, driven by mGluR activity, that functions to modulate dendritic morphology
during neuron development (Figure 32). In this pathway, delta-catenin, when unphosphorylated at
its PDZ-binding motif, promotes dendrite elongation, whereas delta-catenin that is phosphorylated
within this motif (serines at -6 and -3 positions relative to terminal valine) instead promotes
dendritic branching. This work builds on earlier work on the PDZ-binding motif of delta-catenin,
which demonstrated that this motif recognizes and binds a number of PDZ-domain containing
proteins in neurons (Yuan et al. 2015; Arikkath et al. 2008a; Ide et al. 1999). Here, I reveal deltacatenin’s novel binding to the PDZ-domain proteins Magi1 and Pdlim5, each with distinctive roles in
dendrite development. While this report focuses upon the delta:Magi1 versus delta:Pdlim5
complexes, I note that phosphorylation of delta’s PDZ-binding motif is likely to affect additional PDZdomain interactions. This would expand the relevance of delta’s newly revealed phospho-switch
beyond what is already a strong indicator here, where two novel delta-catenin interactions are
shown to promote dendrite lengthening versus branching morphologies.
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Figure 32. Proposed model of delta-catenin signaling during dendrite development.

In the absence of glutamate signaling, delta-catenin remains unphosphorylated at its -3 and -6
serines, allowing it to bind Magi1, which leads to moderate inhibition of RhoA activity, and
ultimately to dendrite elongation. In response to glutamate signaling and Type 1 mGluR activation,
delta-catenin is phosphorylated at its -3 and -6 sites and stops binding Magi1. Instead, delta-catenin
begins binding Pdlim5, which enhances delta-catenin’s inhibition of RhoA activity, contributing to
dendritic branching.
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Delta-catenin in dendrite development
To study the roles of delta-catenin in dendrite development, I opted to utilize a primary rat
hippocampal neuron culture model. This was due to the established characterization of dendrite
morphology and development that has been achieved by the field in this model (Dotti, Sullivan, and
Banker 1988; Banker 2018). The use of a 2D culture model also facilitated analysis of dendrite
morphology when compared to in vivo options. Nevertheless, it will be worth validating these
results in an in vivo model to better understand the full context of delta-catenin’s role in neuronal
development.

The results of my early work on delta-catenin are in agreement with previous findings. Specifically, I
found that overexpression of delta-catenin in hippocampal neurons resulted in a significant increase
in both dendrite length and dendrite branch number. While interesting, these processes (elongation
and branching) are likely mediated by separate pathways, as they fulfill different needs during
neuron development and have separate downstream effectors associated with them (Dong, Shen,
and Bülow 2015). Indeed, my work on delta-catenin supports this theory, as my observations
suggest that delta-catenin induces dendrite elongation or branching via two separate
phosphorylation-dependent pathways. Each of these distinct pathways involve a novel interaction
with either of the PDZ domain-containing proteins, Magi1 and Pdlim5, via the PDZ-binding motif of
delta-catenin.

My findings build upon previous studies which revealed that delta-catenin functions in both the
elongation and branching of developing dendrites (Arikkath et al. 2008a; Martinez et al. 2003;
Matter et al. 2009). Despite the significance of catenin phosphorylation having been previously
observed, the significance of serine modification of delta-catenin, as well as the roles of specific
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phosphorylation sites within the protein, have remained largely ignored (H. Kim, Han, et al. 2008;
Martinez et al. 2003). Martinez et al. showed in 2009 that delta-catenin’s role in dendrite branching
and elongation appears to be influenced by tyrosine and threonine phosphorylation, though specific
sites were not identified. Further, the authors reported that the observed phosphorylation of deltacatenin, in addition to mediating the protein’s roles in dendrite formation, led to the loss of deltacatenin’s association with PSD-95, an interaction dependent on the PDZ-binding motif of deltacatenin. Interestingly, the only phosphorylation sites in this motif are serine residues, providing
further support for the possible significance of phosphorylation events at these sites. Results from
the protein domain microarray described in this work also show a loss of association with PSD-95,
but specifically in response to phosphorylation at either the -3 or -6 serine of delta-catenin (data not
shown). These observations suggest that while phosphorylation of the -3 and -6 serines of deltacatenin may occur in tandem with tyrosine and threonine phosphorylation events, phosphorylation
of delta-catenin’s PDZ binding motif is sufficient to determine whether the protein promotes
dendrite elongation or branching. Taken together, the findings described here serve to elaborate on
the roles of specific phosphorylation sites within delta-catenin and help to reveal the significance of
the phosphorylation state of delta-catenin’s PDZ-binding motif in dendrite development.

The conclusions above are also complimented by previous studies on delta-catenin, which report
that delta-catenin’s function in dendritogenesis requires its PDZ binding-motif as well as its
association with the PDZ-domain of Erbin. Knockdown of Erbin, or deletion of the PDZ-binding motif
of delta-catenin, results in the underdevelopment of dendritic trees, presumably due to deltacatenin failing to be transported to neurites by Erbin (Arikkath et al. 2008a). My results interestingly
suggest that the delta-catenin:Erbin complex is unaffected by phosphorylation of delta-catenin’s
PDZ-binding motif (Figure 6B), in common with additional interactions resolved on the PDZ-domain
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arrays. This suggests that delta-catenin can be transported along developing neurites/dendrites
regardless of its phosphorylation state, though I believe that these phosphorylation events occur
locally, at future branch points of dendrites. Additionally, preliminary indications are that most of
delta’s PDZ-motif interactions are not phospho-dependent like those described here. However, as
noted above, those that are might collectively contribute to wider phospho-switch effects outside of
delta-catenin’s associations with Magi1 and Pdlim5. Overall, this work elaborates on previous
findings in this area of dendrite development and further implicates the PDZ-binding motif of deltacatenin as a key regulator of dendrite morphology.

Roles of Magi1, Pdlim5, and other PDZ Proteins in dendrite development
In addition to building upon the known roles of delta-catenin in neuronal development, these
findings also reveal new roles for PDZ domain-containing proteins in the same context. PDZ domaincontaining proteins have multiple roles in many aspects of neuronal development, ranging from
membrane organization to cytoskeletal remodeling. For instance, in dendrites, the PDZ domaincontaining RacGEF, TIAM-1, is brought into proximity of the WAVE regulatory complex via a PDZdependent interaction in order to stimulate dendritic branching by elevating F-actin assembly in
spatially specific regions along dendrites, though the mechanisms underlying specification of branch
sites remains unknown (Zou et al. 2018). Observations of such proximity-based activity regulation
may help to shed light on the mechanisms by which PDZ proteins influence the activity of deltacatenin in dendrites, making approaches such as APEX and Bio-ID, which identify proteins in close
proximity to a given complex, very appealing for further study of the pathways described in this
work (Hung et al. 2014; Roux et al. 2018). There are also two well-studied MAGUK family members
that may have roles intertwined with the function of delta-catenin in certain contexts. As previously
mentioned, PSD-95 is a MAGUK protein family member that stabilizes AMPA receptors in the
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postsynaptic density via interactions with Stargazin and other auxiliary proteins in complex with
these receptors (X. Chen et al. 2015; Schnell et al. 2002). Magi2 (S-SCAM), like PSD-95, is another
synaptic MAGUK protein that acts as a scaffolding molecule for GluA2-containing AMPA receptors,
and is believed to play a role in synaptic plasticity (Danielson et al. 2012). Both PSD-95 and Magi2
have been found to interact with the PDZ-binding motif of delta-catenin (Ide et al. 1999; J. B.
Silverman et al. 2007). My preliminary findings indicate that much like Magi1, both PSD-95 and
Magi2 interact only with the unphosphorylated PDZ-binding motif of delta-catenin (PSD-95 data not
shown). While beyond the scope of this work, given known synaptic roles of MAGUK proteins such
as PSD-95 and Magi2, as well as PDZ domain-containing proteins in general, my findings suggest that
these proteins may function, in part, via associations with delta-catenin in regions outside of the
dendrite. Accordingly, further research is needed upon these proteins in neural development,
especially within the context of the impact of delta-catenin’s phosphorylation in morphogenesis.

My findings concerning Magi1 further build upon the known roles of MAGUK proteins in neural
development. Prior to this work, very little was known about the function of Magi1 in neuronal
development, with the majority of previous work on the Magi proteins in this context being focused
on the synaptic roles of Magi2 (Stetak et al. 2009; Iida et al. 2004; Meyer et al. 2004). The results
described in this work reveal a new role of Magi1 in neuronal development, in that it promotes
dendritic elongation in developing hippocampal neurons. Exogenous Magi1 expression greatly
increases dendrite length, while the number of dendritic branches appears largely unaffected.
Magi1 knock-down correspondingly results in neurons with shorter dendrites. These roles in
dendrite outgrowth appear to be dependent upon association of Magi1 with delta-catenin, as when
a Magi1 mutant incapable of binding delta-catenin is exogenously expressed, neurons do not
develop significantly longer dendrites. Moreover, when combined with the observation that delta-
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catenin can be manipulated to promote dendrite elongation over branching, these findings further
support the notion that dendrite elongation and branching are mediated by distinct pathways.

Much like Magi1, my findings suggest that Pdlim5 functions in the developing dendrite via its
interaction with delta-catenin. However, unlike Magi1, Pdlim5 promotes dendritic branching rather
than elongation and interacts only with the phosphorylated PDZ-binding motif of delta-catenin. I
found that hippocampal neurons overexpressing Pdlim5 develop significantly more dendrites when
compared to controls, and these neurons exhibit minimal to no changes in overall dendrite length.
Providing support for the dependency of these roles on association with delta-catenin, exogenous
expression of a Pdlim5 mutant unable to bind delta-catenin fails to increase dendritic branching to
the same extent as wild-type Pdlim5. While these findings are consistent with Pdlim5’s role in
dendritic branching being dependent upon its interaction with the phosphorylated PDZ-binding
motif of delta-catenin, understanding how this interaction directly regulates the activity off either
protein will require further study. One potential explanation is that the interaction with Pdlim5
obstructs certain other proteins from binding delta-catenin, thereby changing its ability to regulate
downstream effectors. A second possibility is that Pdlim5 brings delta-catenin into close proximity
with a cohort of proteins that are involved in signaling downstream of delta-catenin activity. While
both of these explanations can help reveal interesting new members of this pathway, further study
will be required to identify the compositions of different protein complexes formed with deltacatenin in the presence or absence of Pdlim5 (and Magi1). Additionally, and unexpectedly, neurons
partially knocked-down for Pdlim5 did not exhibit reduced dendritic branching, but instead showed
increased dendrite length. This suggests some cross-talk between the mechanisms underlying
dendrite branching and elongation, and that Pdlim5 promotes dendrite branching while
simultaneously inhibiting elongation. This observation is in line with previous studies of Pdlim5 that
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revealed its role in PMA-induced growth cone collapse, indicating that the protein may play a role in
outgrowth inhibition (Ren et al. 2015). Because a similar increase in dendrite length was not
observed with overexpression of a Pdlim5 mutant incapable of interacting with delta-catenin, it
suggests that the role of Pdlim5 in the inhibition of dendrite outgrowth may be independent from its
interaction with delta-catenin and subsequent roles in dendrite branching. Taken together, these
findings reveal a novel role for Pdlim5 in the promotion of dendritic branching and inhibition of
dendritic elongation, as well as place it in a phosphorylation-dependent pathway that functions to
mediate dendrite morphology.

Neuronal localization of delta-catenin, Magi1, and Pdlim5
As mentioned above, delta-catenin, Magi1, and Pdlim5 all localize to the dendrites of neurons
during development, as observed with standard confocal microscopy. This is in line with the roles of
these proteins in dendrite elaboration, though I felt that utilizing a higher resolution imaging
technique might shed more light on the potential mechanisms of action for each of these proteins in
this process. Indeed, through the use of super-resolution (STORM) confocal microscopy, I have
revealed for the first time the fine localization patterns of delta-catenin, Magi1, and Pdlim5 along
the dendrites of cultured hippocampal neurons. Interestingly, unlike standard confocal imaging,
which suggests a rather diffuse localization of these proteins, STORM imaging has revealed that both
Magi1 and Pdlim5 localize to very fine filopodia-like structures along the lengths of young dendrites,
with delta-catenin being present at the base of such structures as well as along the length of the
dendrite shaft. While both Magi1 and Pdlim5 were present in these structures, the distribution of
Magi1-positive and Pdlim5-positive filopodia were distinct. The Magi1-positive filopodia appeared to
be primarily localized to the tips of dendrites, whereas the Pdlim5-positive structures were present
along the entire length of the dendrite shafts. This observation of “filopodial” localization of these
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proteins is interesting, as it fits with the belief that neurons (among other cell types) sense their
environment and undergo morphological changes through the use of fine, highly dynamic
protrusions from the cell (Leondaritis and Eickholt 2015; Gauthier-Campbell et al. 2004).

In the case of dendrite development, two primary functions of filopodia have been observed during
branching and outgrowth. At the neurite tip, filopodia of the growth cone function to relay extrinsic
cues to cytoskeletal regulator proteins in order to promote extension of the neurite/dendrite.
Similarly, along the dendrite shaft, filopodia have been shown to function as dendritic branch
precursors, with local increases in Ca2+ triggering a CaM-mediated signaling cascade that results in
the formation of a dendritic branch (Hou et al. 2015; Leondaritis and Eickholt 2015). Accordingly, it is
conceivable that some of these filopodia are responding to extrinsic signals to produce highly
localized pockets of phosphorylated delta-catenin at future dendritic branch points, while others are
responding to distinct cues to facilitate the outgrowth of an established dendrite in a delta-catenindependent manner. The presence of many of these structures along dendrites suggests that they
are dynamic, with most of the Pdlim5-positive filopodia never becoming dendritic branches, while
the enrichment of Magi1-positive filopodia to the tips of dendrites suggests that Magi1 may be
functioning in the elongation of dendrites via roles in signaling events initiated in these structures.
Consequently, understanding how the fate of a given protrusion is determined will be essential in
revealing their roles in dendrite development. Overall, my observations of delta-catenin, Magi1, and
Pdlim5 localization under super-resolution provide insight into the potential mechanisms by which
these proteins influence dendrite development. It will be interesting to observe the fates of these
filopodia (retraction vs. stabilization/growth), as well as identify other proteins and possible
receptors present in them to further reveal their significance.
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Phosphorylation of delta-catenin in developing neurons
Previous analysis of phosphorylation events in the rat brain revealed that both the -6 and -3 serines
of delta-catenin are phosphorylated in vivo, though the significance of these phosphorylation sites
were never addressed (Lundby et al. 2012). My findings help to address the function of these
phosphorylation events, and better describe how delta-catenin modulates dendritic arbor formation
in hippocampal neurons, and likely that of other neuronal cell types. My data suggest that
phosphorylation of the -6 and -3 serines of delta-catenin occurs in a glutamate-dependent manner,
via a signaling cascade initiated by Type1 metabotropic glutamate receptors (mGlur5 and mGluR1).
In untreated neurons, only a small fraction of delta-catenin appears to be phosphorylated, whereas
treatment of hippocampal neurons with the Type 1 mGluR agonist DHPG results in an approximate
13-fold increase in the relative levels of phosphorylated delta-catenin, specifically at the PDZ-binding
motif. While glutamate may not be the sole upstream driver of this pathway, these findings are
supported by previous studies on the role of glutamate in dendrite development, which indicate
that it contributes to dendritic branching during development, as blocking mGluR5 activity during
early development results in neurons with fewer dendrites (H. Park et al. 2007). Nevertheless, it will
be interesting to determine if glutamate is the lone extrinsic signal responsible for mediating this
phosphorylation-dependent regulation of dendrite morphogenesis, or if there are other signals that
also converge on the phosphorylation of delta-catenin to impact dendrite development.

Analysis of the PDZ-binding motif of delta-catenin revealed it to be a MAPK/CDK consensus
sequence. In line with this, my results suggest that the kinase CDK5 may be primarily responsible for
the phosphorylation of the -3 and -6 serines of delta-catenin’s PDZ-binding motif, as co-expression
of a constitutively-active CDK5 with delta-catenin in HEK293 cells results in a nearly 17-fold increase
in relative phosphorylation of delta-catenin at its PDZ-binding motif. CDK5 has been previously

101

implicated in dendrite development, as it is expressed in the growth cones of developing neurites,
with loss of CDK5 function resulting in atypical dendrite morphology in cortical neurons (Margareta
Nikolic et al. 1996; Ohshima et al. 2007). In primary hippocampal neurons, CDK5 has been shown to
be required for BDNF-induced dendritic growth as well as activity-dependent dendritic growth
(Cheung et al. 2007; Liang et al. 2015). Interestingly, CDK5 is also known to be activated by Type1
metabotropic glutamate receptors (mGlur5 and mGluR1) in mouse neostriatal slices, the same
receptors that my findings implicate in the phosphorylation of the PDZ-binding motif in deltacatenin (Liu et al. 2001). Further, CDK5 has been shown to phosphorylate delta-catenin in the
synapse to regulate delta-catenin’s stabilization of AMPA receptors at the synaptic membrane,
though these synaptic phosphorylation events are not within the PDZ-binding motif of delta-catenin.
(Poore et al. 2010). Based on my observations, I propose that CDK5 regulates dendritic branching in
a glutamate dependent-manner via the phosphorylation of delta-catenin’s PDZ-binding motif.
However, additional work is required to understand the extent of CDK5 activity in response to
glutamate signaling, as well as to uncover other kinases that may be responsible for phosphorylation
of delta-catenin’s PDZ-binding motif during dendrite development. While CDK5 appears to function
downstream of the Type 1 mGluRs, given the large amount of crosstalk between the signaling
cascades generated by extrinsic signaling cues in dendrite development, it is possible that additional
receptors lie upstream of CDK5 in terms of delta-catenin phosphorylation. Additionally, while my
initial findings ruled out several other MAPK/CDK proteins, it will be worth investigating whether
CDK5 acts as the sole kinase responsible for phosphorylation of the PDZ-binding motif of deltacatenin, or if other kinases also display some activity in this regard. Further, given the transient
nature of the phosphorylation status of delta-catenin following DHPG treatment (levels return to
baseline within 30 minutes), it is likely that the activity of one or more phosphatases at branch
points of dendrites function as a counterbalance to CDK5-mediated phosphorylation of delta-
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catenin, though more work will be required to reveal the identity of such proteins. Nevertheless, my
findings build upon on the known roles of CDK5 activation in dendritic growth, as well as link CDK5dependent phosphorylation of delta-catenin to a novel regulatory mechanism of dendritic
development.

While slightly beyond the scope of my project, a key aspect of the pathway described in this work is
the initial source of glutamate, and there exist several known potential sources. Primary neurons cocultured with glial cells develop significantly more complex dendritic arborizations than those
cultured in the absence of glial cells (Buard et al. 2010; Procko and Shaham 2010). There also exists
evidence of glial glutamate release and uptake modulating synaptic activity and dendritic spine
morphology, further implicating glial cell-derived glutamate signaling as a regulator of neuron
morphogenesis (Angulo 2004; Verbich et al. 2012). This raises the question of whether the glial cells
supporting neuron development and function are providing dendritic growth cues via the regulation
of local glutamate levels.

Indeed, it has been shown that a significant portion of extracellular glutamate in the hippocampus
(and other areas of the brain) is the result of nonvesicular release from astrocytes, with evidence
supporting the involvement of glial cysteine-glutamate antiporters in this process (HerreraMarschitz et al. 1996; Jabaudon et al. 1999; Baker et al. 2002). However, there is also evidence that
glia-induced dendritic branching occurs via glutamate-independent mechanisms, suggesting that the
lack of dendritic branching in neurons cultured without glial cells may not be the result of an
absence of glutamate release. In this context, it was recently shown that astrocytic Phospholipase
D1 functions to promote dendritic branching through the production and ultimate secretion of
phosphatidic acid. This phosphatidic acid release leads to the activation of Protein Kinase A in
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neurons, which has been identified as a component of several developmental signaling pathways in
neurons, such as those induced by Semaphorin signaling, and is believed to promote dendritic
branching (Zhu et al. 2016; Song and Poo 1999; Puram and Bonni 2013). Building on these findings,
it has similarly been revealed that several glia-derived axonal guidance cues can also mediate
dendritic outgrowth, including Semaphorin, Netrin, and Slit family members, adding further to the
list of potential glutamate-independent mechanisms by which glial cells may influence dendrite
branching in neurons (Furrer et al. 2003; Godenschwege et al. 2002; S. Kim and Chiba 2004; Polleux,
Morrow, and Ghosh 2000). A second possibility is a neuronal source of glutamate. Recent evidence
suggests that spontaneous axonal release of glutamate prior to synapse formation plays a significant
role in establishing the complexity of the dendritic arbor (Andreae and Burrone 2015). Non-synaptic
glutamate signaling is additionally reported to promote dendritic branching and outgrowth via the
down-regulation of Bcl11A-L by NMDAR activation, with stimulation of these receptors leading to
neurite branching, and inhibition promoting neurite outgrowth (Kuo, Chen, and Hsueh 2010). The
source of glutamate in this pathway is believed to be largely axonal, stemming from extrasynaptic
diffusion of neurotransmitters in young neurons. Interestingly, this glutamate diffusion is thought to
occur only during early development, before the formation of synapses, and occurs independently
of the traditional glutamate transporters found on the surface of glial cells (Demarque et al. 2002).
While my findings support existing and propose new mechanisms of dendrite development
downstream of glutamate signaling, a significant amount of work is still needed to fully understand
how such upstream external cues intersect with the intrinsic morphological signaling pathways that
underlie dendrite morphology. Identifying the source of glutamate in the pathway described in this
work will mark an integral point in the furthering of our understanding of dendrite development, as
well as reveal new targets for potential therapeutic intervention for numerous neurodevelopmental
disorders.

104

Downstream effectors of delta-catenin phosphorylation in dendrite development
Given that the elaboration of dendritic arborizations is almost entirely dependent on the regulation
of cytoskeletal remodeling events, it is likely that the phosphorylation of delta-catenin and its
subsequent association with Magi1 or Pdlim5 lead, in part, to the modulation of at least some of the
many proteins underlying actin or microtubule dynamics in dendrites. As previously mentioned, the
Rho family of small GTPases has extensive roles in neurite development and maintenance via
cytoskeletal remodeling, and are perhaps the best described cytoskeletal regulatory proteins in this
regard (Govek, Newey, and Van Aelst 2005). Specifically, RhoA activity has been shown to inhibit
dendritic branching in hippocampal neurons, with expression of a constitutively active RhoA leading
to neurons forming significantly less complex dendritic arbors (AY Nakayama, Harms, and Luo 2000).
This is likely to occur through the regulation of actin assembly via ROCK, and/or through the
inhibition of Cypin expression, a protein that acts to promote microtubule assembly in dendrites (H.
Chen and Firestein 2007). Additionally, RhoA activity is known to be inhibited by delta-catenin, via
an interaction with and sequestration of the RhoA activator, p190RhoGEF, ultimately preventing it
from activating RhoA (H. Kim, Han, et al. 2008). A second Rho family member, Rac1, has been shown
to function in the formation of dendrite branches, and promotes dendritic branching in developing
hippocampal neurons (Vadodaria et al. 2013). Cdc42, a third Rho-family GTPase, also promotes
dendrite formation and elaboration in hippocampal neurons, with expression of a dominantnegative Cdc42 resulting in a decrease in dendritic elaboration in vivo (Threadgill, Bobb, and Ghosh
1997; Vadodaria et al. 2013). All three of these GTPases have been found to function as downstream
effectors of numerous extrinsic signaling cues that mediate dendrite development, with glutamate
signaling playing a major regulatory role in the activity of the proteins in various contexts. For
instance, RhoA activity has been shown to be downregulated via activation of the AMPA glutamate
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receptor during synaptic remodeling (Kang, Guo, and Huganir 2009). There is also evidence
supporting the activation of Cdc42 by CDK5 during neuronal development, as well as its activation in
a glutamate-dependent manner in dendritic spines during their formation and remodeling (Cheung
et al. 2007; Murakoshi, Wang, and Yasuda 2011). Additionally, both Rac1 and Cdc42 are known to be
activated in response to Type 1 mGluR stimulation via DHPG treatment in hippocampal neurons,
further implicating these cytoskeletal regulators in glutamate-dependent dendritic branching (AbuElneel et al. 2008). Interestingly, activity of both Cdc42 and Rac1 has been shown to increase in
response to delta-catenin expression in hippocampal neurons (Abu-Elneel et al. 2008). Further,
expression of dominant-negative Rac1 in hippocampal neurons prevents increased dendritic spine
formation in response to delta-catenin overexpression, suggesting that the functions of these
proteins may be intertwined (Abu-Elneel et al. 2008). However, it is worth noting that other groups
have reported no change in the activity of either Rac1 or Cdc42 in response to delta-catenin
expression levels, suggesting that delta-catenin’s impact on dendritic morphology may not be
dependent on global activation of Rac1 and Cdc42, but rather regulation of these proteins in highly
localized environments within the cell (Arikkath et al. 2008a; H. Kim, Han, et al. 2008).

Previous findings indicate that the inhibition of RhoA activity by delta-catenin is dependent on the
phosphorylation of Thr-454 in delta-catenin and the protein’s subsequent interaction with and
sequestration of p190RhoGEF (H. Kim, Han, et al. 2008). There is also evidence that overexpression
or loss of delta-catenin may not necessarily affect total levels of active RhoA in neurons, as is the
case for Rac1 and Cdc42 (Arikkath et al. 2008a). Combined with the contradictory findings by the
field on delta-catenin’s effect on global levels of Cdc42 and Rac1, these observations suggest that
delta-catenin’s modulation of Rho-family GTPase activity may depend on microenvironmental
factors, distributed unevenly within single cells, that promote or inhibit post-translational
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modifications of delta-catenin, such as phosphorylation. In the work described here, I focused my
attention upon modulation of GTPase activity in response to the newly discovered phospho-switch
in delta-catenin’s carboxyl-terminal PDZ-binding motif. While I observe a global decrease in RhoA
activity in HEK293 cells in response to the exogenous expression of a phospho-mimic delta-catenin
which preferentially interacts with Pdlim5 (and promotes dendritic branching), I believe that
phosphorylation of delta-catenin at its -6 and -3 serines normally occurs in highly localized dendritic
(or other) regions as opposed to throughout a large volume of the neuron, and thus that the total
cellular levels of RhoA-activity remain largely unaltered under normal conditions. Instead, I posit
that localized sub-dendritic regions of increased RhoA inhibition arise upon delta:Pdlim5 association
(phosphorylation of delta -6 and -3 serines), that I conjecture helps to initiate dendritic branching or
to stabilize branches at these loci. This is in line with some previous findings, which report no global
changes in Rho-family GTPase activity in response to delta-catenin over expression, as changes in
the activity of these proteins would still be occurring in specific subcellular environments, regardless
of delta-catenin expression levels. Even when the delta-catenin overexpression phenotypes are
taken into consideration, branch points along the dendrites of a neurons represent a minor portion
of the total cellular volume, meaning that observations of a global change in GTPase activity would
be inconsistent, or possibly undetectable altogether in most cases. While future work on the
downstream effectors of the pathway described here is clearly required, I suspect that deltacatenin’s reported ability to modulate the activity of Rho-family small GTPases, and possibly other
downstream modulators of microfilaments or microtubules, is linked to delta-catenin’s
phosphorylation-dependent interactions with Magi1 versus Pdlim5.

As would be anticipated, there are prior examples of catenin-protein functions being dependent
upon phosphorylation-dependent interactions with partner proteins, though none of these reports
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have focused on the PDZ-binding motifs of the catenins (Gottardi and Gumbiner 2004; Gu et al.
2011; Hong, Oh, and McCrea 2016; Nusse and Clevers 2017). I note also that the “phospho-switch”
mechanism revealed in this work within delta-catenin may also be present in certain additional
catenin proteins. For example, p0071-catenin possesses an identical PDZ-binding motif to that of
delta-catenin, inclusive of the noted -6 and -3 serine residues (Izawa et al. 2002). While relatively
little is known about p0071-catenin, it is known to function in cytokinesis through modulation of
RhoA activity (Keil et al. 2007). It is conceivable that the regulatory functions of p0071 are also
mediated, in part, by phosphorylation of its PDZ-binding motif in a fashion similar to that of deltacatenin. Thus, I view it as probable that the further elucidation of delta-catenin’s phospho-switch
and its downstream effectors in neurons will shed light upon the function of catenins in other cell
and tissue types.

While my findings, as well as those of previous studies, suggest that small-GTPases are relevant to
the functions of delta-catenin in neuronal development, delta-catenin has also been found to
function independently of these proteins in this context. Specifically, delta-catenin has been shown
to promote neurite elongation and branching upon the phosphorylation-dependent binding of
cortactin, an actin-associated protein that induces actin nucleation through association with the
Arp2/3 complex (Martinez et al. 2003). Thus, the delta-catenin:Magi1 and delta-catenin:Pdlim5
complexes and subsequent small-GTPase modulation revealed by my findings may function in
parallel with the actin nucleation events initiated by a delta-catenin:cortactin complex, or other
delta-catenin protein complexes, to dynamically mediate dendrite branching and elongation during
development. It may also be the case that the delta-catenin:Magi1 and delta-catenin:Pdlim5
complexes are directly influencing delta-catenin’s regulation of cortactin or other cytoskeletal
regulatory proteins. To more completely understand their mechanisms of action, it will be important
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in the future to identify additional down-stream effectors of the delta:Magi1 and delta:Pdlim5
complexes, as well as to identify any potential proteins brought into complex with delta-catenin as a
result of these associations. Methods such as Split Bio-ID, which can reveal the identity of proteins
brought into association with a given protein complex (delta-catenin:Pdlim5, for example), will be
especially useful in this endeavor (Schopp et al. 2017). Finally, it will be informative to probe for the
role of sub-cellular environments, within individual dendrites, in the modulation of delta-catenin
phosphorylation and subsequent GTPase regulation. For example, if the pinpointed stimulation of
mGluRs locally enhances delta-catenin:Pdlim5 complex formation, to contribute to branching versus
lengthening outcomes, or if more broadly present glutamate increases instead generate intrinsic
cascades (involving delta-catenin) leading to dendrite branching. Such information will be helpful in
determining how extrinsic signaling cues functionally converge on intrinsic effectors, such as the
Rho-family small GTPases.

Potential roles of delta-catenin phosphorylation outside of dendrite development.
The pathway described in this work was primarily investigated from the perspective of dendrite
development. However, given the roles of delta-catenin and many PDZ domain-containing proteins
in the development and maintenance of other neuronal compartments, such as the synapse and
axon, where effectors such as the Rho-family GTPases play a major role, it is entirely conceivable
that these proteins function in these areas as well.

While my preliminary findings suggest that overexpression or knockdown of delta-catenin, Pdlim5,
or Magi1 in hippocampal neurons does not impact dendrite-axon specification (as evidenced by
manipulations occurring at 1DIV), it will be interesting to reveal whether these proteins play a role in
axon behavior or morphology in the time after specification. The presence of delta-catenin, Pdlim5,
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and Magi1 in filopodia-like structures along dendrites, as well as in neurite growth cones, may
provide clues to the function of these proteins in axon development. As is believed to be the case
for dendrites, axon branches also originate on dynamic filopodial protrusions, many of which never
become branches (Kalil and Dent 2014). Additionally, at the growth cones of axons, Pdlim5 has been
shown to function in the collapse of these structures, thus restricting axon outgrowth (Ren et al.
2015). The results described here suggest a similar role of Pdlim5 in the restriction of dendrite
outgrowth, raising the question of whether Pdlim5’s dendritic branching roles also extend to axons.
Further, a key step in both axon outgrowth and axon branching is the reorganization of actin
filaments, a process that my findings, as well as those of previous studies, reveal may be influenced
by delta-catenin (K. Kim et al. 2002; Dent, Gupton, and Gertler 2011). The Rho-family GTPases RhoA
and Rac1, whose activity has been shown to be regulated by delta-catenin, are both crucial for
normal axonal growth (Woo and Gomez 2006; Abu-Elneel et al. 2008; H. Kim, Han, et al. 2008).
Neurons lacking Rac1 exhibit increased stalling in outgrowth and guidance defects in vivo (Hua,
Emiliani, and Nathans 2015). Axon development is similarly dependent on the appropriate
regulation of RhoA activity, with RhoA activity being required for activity-dependent axon branching,
axon regeneration, and the inhibition of axonal outgrowth during guidance (Lehmann et al. 1999;
Fujita and Yamashita 2014; Hu and Selzer 2017; Ohnami et al. 2008). Taken together, these roles for
the RhoA GTPases in axon development, combined with the overlap between the cascades
generated by glutamate signaling and several other extrinsic axonal/dendritic guidance cues
(described in Introduction), suggests that the pathways governing axon morphology may also
involve the phosphorylation of delta-catenin and subsequent interactions with Pdlim5 or Magi1.
Because of the potential overlap in dendritic and axonal roles of the proteins described in this work,
more research will be required to fully elucidate the extent of the function of these proteins in
neurite outgrowth and elaboration.
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At the synapse, specifically the postsynaptic density, there similarly exists potential roles for each of
these proteins in signal transduction and cytoskeletal remodeling. Both delta-catenin and Pdlim5
have been implicated in synapse development (Joshua B Silverman et al. 2007; Herrick et al. 2010;
Kosik et al. 2005). Previous studies have revealed that delta-catenin plays a role in mediating
activity-induced synaptic remodeling, and is crucial for the formation of an appropriate density of
dendritic spines along dendrites (Arikkath et al. 2009). Interestingly, these roles appear to be
dependent on the presence of delta-catenin’s PDZ-binding motif, as deletion of this region results in
similar phenotypes as loss of delta-catenin in neurons (Arikkath et al. 2009). While the identity of
the PDZ domain-containing interaction partners tied to these roles of delta-catenin remain largely a
mystery, both PSD-95 and S-SCAM (Magi2), which have well-established roles in synaptic
development and maintenance, have been revealed to interact with this region of delta-catenin
(Schnell et al. 2002; E. Kim and Sheng 2004; Iida et al. 2004; Lu et al. 1999; Ide et al. 1999; AbuElneel et al. 2008). Additionally, Pdlim5 has also been shown to function in the restriction of
dendritic spine size, a process that is integral to synaptic plasticity in the central nervous system
(Konietzny, Bär, and Mikhaylova 2017; Herrick et al. 2010). Interestingly, my findings demonstrate
that both PSD-95 and Magi2 only interact with the unphosphorylated PDZ-binding motif of deltacatenin, suggesting that phosphorylation of this motif may also be relevant in synaptic
compartments, as it is in the dendrite. These findings may be directly relevant to the synaptic roles
of delta-catenin phosphorylation, as the neuronal roles of Magi1 appear to be mostly localized to
dendrites, but the described roles of Magi2 are conversely largely in the dendritic spine and
postsynaptic density (Iida et al. 2004; Danielson et al. 2012). Thus, it is conceivable that there exists
a similar phospho-switch function of delta-catenin at the synapse as what I observe in dendrites,
although with Magi2 taking the place of Magi1 in this context. Given the synaptic roles of deltacatenin, Pdlim5, Magi2, and several other PDZ domain-containing proteins that interact with delta-
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catenin, it will be worth investigating the function of delta-catenin phosphorylation in synapse
development.

To summarize, the results from this study implicate delta-catenin in a novel phosphorylationdependent pathway mediating dendrite morphology in hippocampal neurons that occurs through
delta-catenin’s interactions with Magi1 versus Pdlim5. My findings provide evidence that this deltacatenin “phospho-switch” operates during dendrite development, contributing to decisions of
elongation versus branching, which occur countless times during formation of the CNS (and PNS), as
well as in neuronal repair and pathological contexts. Further study is needed to determine the
extent of the significance of this “phospho-switch” in neuronal compartments beyond the dendrite,
and will further shed light on the vast and complex roles of delta-catenin in the nervous system.
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Chapter IV

Materials and Methods
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Cell Culture and Transfection of HEK293 cells.
For most biochemical assays and the Golgi Co-relocalization Assay, I utilized HEK293 cells. This cell
line was chosen due to its high transfectability and convenient lack of endogenous delta-catenin,
resulting in an environment where perturbations to delta-catenin will not have to compete with the
endogenous protein. HEK293 cells were purchased from ATCC and maintained in DMEM cell culture
media (Sigma-Aldrich) supplemented with 10% FBS (Sigma-Aldrich) and 1x penicillin-streptomycin
(Life Technologies). Culture media was changed every other day until cells reached 80% confluency,
at which point they were passaged into a new culture dish, or plated into 6-well plates. HEK293 cells
were transfected using Lipofectamine 3000 and the manufacturer’s recommended protocol. Cells
were transfected at 50-60% confluency per well in a 6-well culture plate. For Golgi Co-relocalization,
cells were fixed and imaged 24 hours after transfection and examined via confocal microscopy. For
validation of shRNA-mediated knockdowns and for immunoprecipitation analyses, HEK293 cells
were lysed 24-48 hours post-transfection. Cell lysates were then subjected to the appropriate
biochemical analyses, as described below.

Cell culture and transfection of neurons.
Primary hippocampal neurons were kindly provided by Dr. Neal Waxham, and were isolated from rat
embryos (E18) as previously described (Fischer et al. 2018). For morphological analyses,
hippocampal neurons were plated in 24-well tissue-culture plates (2x105 cells/well), containing glass
coverslips coated with 100μg/ml poly-D-lysine (Sigma Aldrich). For biochemical analyses,
hippocampal neurons were plated in 6-well culture plates (1x106 cells/well) to provide an adequate
amount of cell lysate for analysis. All hippocampal cultures were maintained in Neurobasal Medium
(Life Technologies) supplemented with B-27 (Life Technologies), GlutaMAX (Life Technologies), and
penicillin-streptomycin (Life Technologies) for a total of 7 days for most analyses (Neurons used for
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characterization of delta-catenin, Magi1, and Pdlim5 expression were grown in culture for up to 28
days). For transfections, at 3 days in vitro (DIV), neurons were transfected using Lipofectamine 3000
with 1µg of plasmid DNA and a modified manufacturer’s protocol (Life Technologies). All cDNA
transfections for overexpression analyses utilized cDNA in the pCS2 expression vector. All shRNAmediated knockdowns utilized the pSUPER shRNA expression vector (Oligoengine). To visualize
expression of exogenous vectors in culture, all cDNA constructs of delta-catenin, Magi1, and Pdlim5
were epitope tagged (HA-delta-catenin; Flag-Magi1; and Myc-Pdlim5). To confirm successful
transfection of shRNA, the pSUPER vector utilized a bicistronic GFP or mOrange fluorescent marker.
This allowed for efficient identification of transfected neurons without compromising the
functionality of the transfected shRNA.

DNA Constructs.
All DNA constructs were cloned into the pCS2 mammalian expression vector by the McCrea
Laboratory. All truncations, deletions, and site mutations were generated via PCR and confirmed
with DNA sequencing performed by the MDACC Sequencing Core. Full length delta-catenin
constructs contain an N-terminal HA epitope tag, and a stop codon immediately following the Cterminal of delta-catenin, to best preserve the function of the C-terminal PDZ-binding motif. I found
that the use of a C-terminal epitope tag blocks the DPZ-binding motif from interacting with its target
PDZ domains of other proteins. The shRNA-resistant delta-catenin construct was obtained from
Jyothi Arikkath and has been described in previous studies (Arikkath et al. 2008a). Briefly, the
construct utilizes a series of silent mutations to render it resistant to our delta-catenin shRNA (Also
provided by Jyothi Arikkath). This delta catenin construct was cloned into a pCS2-HA vector by the
McCrea Laboratory, and was used as the backbone for the delta-AA and delta-EE shRNA-resistant
delta-catenin constructs. I opted to use the shRNA-resistant delta-catenin for these mutations, as it
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would be immediately usable in delta-catenin shRNA-mediated knockdown settings that may be
desirable to study in the future. All Magi1 constructs in this project utilized a pCS2-FLAG vector,
while the Pdlim5 constructs used a pCS2-Myc vector. All kinase constructs used (dnCDK5, CDK5,
p25C, and MKK7) utilized the pcDNA3-GFP expression vector and were kind gifts from Jeff Frost, PhD
(UTHealth). Vector controls utilized either the pCS2 (+GFP) or pSUPER (+GFP or mOrange) vector.

shRNA Synthesis and validation.
The Oligoengine pSUPER-GFP and pSUPER-mOrange shRNA vectors were used as the backbone for
all shRNA constructs utilized in this project. For Magi1 and Pdlim5 shRNA, target sequences 19
nucleotides in length were identified via the siRNA Wizard v3.1 tool (InvivoGen) and used to
generate the hairpin RNA that would ultimately be transfected into neurons. Following design,
Magi1 and Pdlim5 shRNA sequences were purchased from GE Dharmacon, then annealed and
inserted into the pSUPER-GFP vector following the manufacturer’s protocol (Oligoengine). The deltacatenin shRNA (pSUPER-mOrange) was a kind gift from Jyothi Arikkath (University of Nebraska) and
has been validated and published as part of several studies on delta-catenin (Arikkath et al. 2009,
2008a). All construct sequences were validated via the DNA sequencing facility at MD Anderson
Cancer Center. The sequences for the shRNA targeting each protein are as follows:
Delta-catenin: TAGAAGTCGACATAGTTGC
Magi1: GGAATGTGATACGTGTCTA
Pdlim5: GCACTGTATTGTGAGCTAT
Knockdown efficiency of each shRNA construct was validated via transient transfection of HEK293
cells expressing either HA-delta-catenin, FLAG-Magi1, or Myc-Pdlim5 with the respective shRNA
construct. HEK293 cells were used here because of their high transfectability and the difficulty in
performing culture-wide biochemical analyses of transfected primary neuron cultures. Cells were
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allowed to grow for 24-48 hours before lysis. To quantify knockdown efficiency, the cell lysates were
subjected to western blot analysis. Western blots were quantified using densitometry (ImageJ) to
calculate a general knockdown efficiency percentage for each shRNA. I noticed a near complete loss
of delta-catenin protein levels in HEK293 cells transfected with shRNA. Both Magi1 and Pdlim5
exhibited partial knockdown, with a ~68% loss of Magi1 and ~40% loss of Pdlim5 in shRNAexpressing cultures. While it will be interesting to achieve a more complete knockdown of Magi1
and Pdlim5, as demonstrated above, my data show that even a partial knockdown of either protein
in hippocampal neurons is sufficient to generate morphological changes (Figures 17 and 19).

Protein Domain Microarray:
The protein domain microarray was conducted by the laboratory of Mark Bedford, PhD at the MD
Anderson Protein Array and Analysis Core. A comprehensive library of human PDZ protein domains
was cloned into a pGEX vector by Biomatik (Cambridge, Canada) using gene synthesis to best
optimize the open reading frames for bacterial expression. Escherichia coli was used to express the
protein domains as GST fusions, which were purified using glutathione-Sepharose beads. The
recombinant domains were arrayed onto nitrocellulose-coated glass slides (Oncyte®vid slides, Grace
Bio-Labs, Bend, OR), using an Aushon 2470 pin microarrayer, as previously described (A. Espejo et al.
2002). The slides were probed with biotinylated delta-catenin PDZ-binding motif peptides (CPC
Scientific, Sunnyvale, CA). Following probing, fluorescent signal was detected with a GenePix 4200A
Microarray Scanner (Molecular Devices).

Identification of critical residues in Magi1:delta-catenin and Pdlim5:delta-catenin complexes:
Identification of the residues in the PDZ domains of Magi1 and Pdlim5 required to bind the PDZbinding motif of delta-catenin was carried out by our collaborator Xiaojiang Chen, at the University
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of Southern California. In order to generate a rough model for prediction of peptide docking, a
homology model for mgiPDZ5 was creating using the SWISS-MODEL prediction server (Biasini et al.
2014; Bienert et al. 2017; Guex, Peitsch, and Schwede 2009; Benkert, Biasini, and Schwede 2011)
using chain B of the previously reported mgPDZ1 structure (Y. Zhang et al. 2007) that comparatively
has a sequence identity of 33%. This solution was then used as input into the Rosetta FlexPepDock
server (London et al. 2011; Raveh, London, and Schueler-Furman 2010), using the placement of the
bound E6 peptide as a relative starting point and using the default run options recommended by the
server. Upon confirmation of model convergence, the resulting top solution was then energy
minimized using the ROSETTArelax application, with a thorough search completed using energy
parameters guided by the Talaris2014 weighting. Relax parameters were chosen to optimize packing
and bonding interactions, with mild constraints towards the input coordinates, and largely default
options were used. The resulting minimized solution was then reported as the standard
configuration within this manuscript.

Golgi Co-relocalization Assay:
I found these two delta-catenin complexes to be quite sensitive to the harsh conditions associated
with cell lysis for traditional methods such as co-immunoprecipitation, causing results obtained from
these assays to be unreliable. To avoid this issue, I developed a novel protein-protein interaction
assay, called the Golgi Co-relocalization Assay (GRA). This assay allows for the visualization of
protein-protein interactions with higher sensitivity and reproducibility than with techniques relying
on cell lysis. In this GRA, a single protein (delta-catenin) is redirected to the Golgi apparatus, causing
any interaction partners of the protein to also relocalize to the Golgi. Since GRA avoids detergent
lysis and wash conditions involved in co-immunoprecipitations, weaker or transient interactions
have a higher probability of being detected. In order to relocalize delta-catenin to the Golgi, I
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synthesized a fusion protein consisting of full-length delta-catenin with the known Golgi Localization
Sequence (GLS - see below) from mTOR fused to the protein’s N-terminus (in order to preserve
function of the PDZ-binding motif). The reason for using this particular sequence is that it remains
functional at both the N-terminal and C-Terminal of most proteins, unlike many other organelle
localization sequences (such as mitochondrial outer membrane localization sequences). Following
transfection, cells were subjected to a standard immunofluorescence staining protocol, as described
below, and were qualitatively analyzed for relocalization of potential partner proteins to the Golgi
with the delta-catenin+GLS fusion protein. Since this assay was performed in HEK293 cells, which
conveniently lack endogenous delta-catenin, competition of this fusion protein with the endogenous
protein for interaction partners was not a concern.
GLS from mTOR:
ACTAGTGAAATGCTGGTCAACATGGGAAACTTGCCTCTGGATGAGTTCTACCCAGCTGTGTCCATGGTGGCCC
TGATGCGGATCTTCCGAGACCAGTCACTCTCTCATCATCACACCATGGTTGTCCAGGCCATCACCTTCATCTTC
AAGTCCCTGGGACTCAAATGTGTGCAGTTCCTGCCCCAGGTCATGCCCACGTTCCTTAACGTCATTCGAGTCTG
TGATGGGGCCATCCGGGAATTTTTGTTCCAGCAGCTGGGAATGTTGGTGTCCTTTGTGAAGAGCCACATCAGA
CCTTATATGGATGAAATAGTCACCCTCATGAGA

Detection and Quantification of phosphorylated delta-catenin:
Considering the importance of delta-catenin’s phosphorylation to this project, it was imperative to
develop a method for detection of changes in relative levels of phosphorylated delta-catenin.
Phosphorylation of delta-catenin’s PDZ-binding motif was detected through the use of a commercial
monoclonal rabbit antibody (Cell Signaling Technologies) directed against a known phosphoMAPK/CDK consensus (PXS*P), that I found to be present within the PDZ-binding motif of deltacatenin. The consensus serine is present at the -6 residue position counting from delta’s terminal
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valine (YPASPDSWV). When used alone, this phospho-MAPK/CDK consensus sequence antibody is
not specific to delta-catenin and will recognize numerous other proteins with similar phosphorylated
sequences. However, when used in combination with a separate monoclonal delta-catenin specific
antibody (BD Technologies), I was able to quantify the relative amount of phosphorylation at the -6
serine position within delta’s PDZ-binding motif. This was accomplished via immunoprecipitation of
phospho-proteins from cell lysates using the phospho-MAPK/CDK consensus (PXS*P) antibody,
followed by western blot analysis during which I stained the resulting membranes with a
monoclonal delta-catenin-specific antibody. The resulting 150kD band on my western blot
membranes represented the relative amount of delta-catenin with a phosphorylated PDZ-binding
motif when compared to the total amount of delta-catenin in the lysed cells, allowing for semiquantitative analysis of delta-catenin phosphorylation.

I validated the specificity of the p-MAPK/CDK antibody to the -6 serine position within delta-catenin
by expressing wild-type versus phosho-null (S1242A, S1245A) constructs of delta-catenin in HEK293
cells, followed by immunoprecipitation and immuno-blotting, as described above (Figure 26). I
detected phosphorylation in exogenously expressed wild-type delta-catenin, but not in the
phospho-null point mutant, where the -6 and -3 serines had been mutated to alanine. This suggests
that the anti-Phospho-MAPK/CDK consensus antibody, when combined with a delta-catenin-specific
antibody, is capable of specifically reporting upon the relative phosphorylation levels of deltacatenin’s PDZ-binding motif.

RhoA Activity Assay:
To quantify changes in RhoA activity, the RhoA G-LISA kit from Cytoskeleton, Inc. was used. For this
solid phase ELISA-based assay, the manufacturer’s protocol was followed. Briefly, HEK293 cells were
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cultured and transfected as described above. At 24 hours post transfection, the cells were lysed and
lysates were subjected to an active RhoA-specific luminescence-based ELISA. Relative luminescence
was measured with a FLUOstar Omega Microplate Reader (BMG Labtech) and normalized to blanks
(lysis buffer alone) and compared to controls.

Proximity Ligation Assay:
To detect direct interactions between endogenous proteins, a Proximity Ligation Assay (PLA) was
utilized. For this assay, hippocampal neurons were cultured and maintained, as described above,
until fixation at 7DIV. The PLA kit I used was manufactured by Duolink (now part of Sigma-Aldrich)
and purchased from Sigma-Aldrich. The manufacturer’s protocol was followed during this assay.
Briefly, cells were permeabilized, blocked, and incubated with primary antibodies, similar to our
protocol for immunofluorescence staining. Following primary antibody incubation, the cells were
washed with PBS, and incubated with Duolink PLA probes, which recognize the primary antibodies,
before being incubated with a ligase and amplification enzymes to generate a DNA structure which
is recognized by the fluorescent probes provided with the kit. Finally, cells were incubated with said
fluorescent probes and imaged using a Nikon T2i Inverted Confocal Microscope with an Apo-Plan
60x 1.4NA Oil objective at pixel size of 100nm. Stacks were converted to maximum projection
images for analysis. Puncta were quantified using the Puncta Analyzer plugin for the ImageJ
software. Puncta/cell ratios were then compared to control groups.

Co-Immunoprecipitation and Western Blots:
For all immunoblotting assays, cells were cultured, maintained, and transfected as described above.
For assays involving HEK293 cells, cells were lysed 24-48 hours post-transfection. For those utilizing
neuronal cultures, cells were lysed at 7DIV (no transfection). Neurons were treated with
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pharmacological agents (DHPG, Cayman Chemicals) at 7DIV (15 minutes to 3 hours before lysis). For
co-immunoprecipitation, an established and familiar protocol in the McCrea Lab was followed.
Following lysis, protein concentrations of cell lysates were measured and equalized using a Bradford
protein assay (Bio-Rad). Equalized cell lysates were then incubated with primary antibodies in 1.5ml
conical tubes for 1 hour at 4°C while rotating. After 1 hour, A/G agarose (Santa Cruz
Biotechnologies) beads were added to each tube and incubated for an additional 1 hour at 4°C while
rotating. Following this secondary incubation, protein was eluted from beads through the addition
of 2x Sample Buffer with βME and heated at 95°C for 5 minutes. Eluted immunoprecipitation
samples, and in the case of western blots, equalized cell lysates, were then loaded into an 8%
acrylamide gel and ran for 120 minutes. Proteins were then transferred to nitrocellulose membranes
(GE Whatman) using a Pierce Power Blotter (Thermo Scientific). Resulting protein-loaded
membranes were then blocked in a TBST + 1% dry milk solution overnight at 4°C. Blocked
membranes were incubated in primary antibodies overnight at 4°C before being incubated in HRP
conjugated secondary antibodies (Invitrogen). Lastly, membranes were incubated with SuperSignal
West luminol solution (Thermo Scientific) and imaged using autoradiography film and a X-OMAT
Developer.

Immunofluorescence Staining:
Immunostaining of HEK293 and primary hippocampal neurons was completed using an established
and familiar protocol (M. Lee et al. 2014). Briefly, cells cultured on Poly-D-lysine coated coverslips
were fixed with 4% paraformaldehyde for 10 minutes at room temperature and then permeabilized
with 0.5% Triton X-100 solution for 15 minutes. Following fixation and permeabilization, cells were
blocked with PBS containing 1% bovine serum albumin overnight at 4°C. After blocking overnight,
cells were incubated with indicated primary antibodies overnight at 4°C, and then rinsed three times
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with fresh PBS for 10 minutes each, followed by an overnight rinse with PBS at 4°C. Cells were then
incubated with Alexa Fluor fluorescent dye conjugated secondary antibodies (Invitrogen) for 1 hour
a room temperature, before the cover slips were finally mounted onto glass slides with Vectashield
anti-fade mounting solution (Vector Laboratories). Prepared cells were visualized using a Nikon T2i
Inverted Confocal Microscope with an APO-PLAN 60x 1.4NA oil objective. All z-series images were
acquired at a pixel size of 100nm and a step size of 0.2µm.

Antibodies:
All anti-HA, -Myc, and -FLAG (mouse monoclonal and rabbit polyclonal) were purchased from SigmaAldrich. The rabbit polyclonal delta-catenin antibody used for immunofluorescence was purchased
from Sigma-Aldrich, while the mouse monoclonal delta-catenin antibody used for western blot
analysis was purchased from BD Transduction Laboratories. All Magi1 and Pdlim5 (mouse
monoclonal and rabbit polyclonal) were purchased from Sigma-Aldrich. The P-MAPK/CDK antibody
used in delta-catenin phosphorylation assays was purchased from Cell Signaling Technologies.

STORM Imaging:
The acquisition of super-resolution confocal images was accomplished with the assistance of Dr.
Adriana Paulucci-Holthauzen and utilized the Nikon N-STORM microscopy system in the MD
Anderson Genetics Department Microscopy Core. For all super-resolution imaging, the
manufacturer’s protocol was followed (Nikon N-STORM). Briefly, primary hippocampal neurons
were isolated, as previously described, and plated onto 35mm MatTek dishes coated with poly-Dlysine. Cells were fixed for 10 minutes at room temperature with 4% paraformaldehyde, and
permeabilized with 0.5% Triton X-100 solution for 15 minutes. The cells were then blocked with PBS
containing 1% bovine serum albumin for 90 minutes at room temperature before incubating
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overnight at 4°C in primary antibodies (1:500 dilution). The cells were then washed 5 times with PBS
for 15 minutes each (75 minutes total), followed by an incubation with secondary antibodies (Atto
488 and Atto 647N) for 1 hour at room temperature (1:500 dilution). Lastly, the cells were washed
another 5 times with PBS for 15 minutes each (75 minutes total), and finally fixed a second time with
4% paraformaldehyde (no shaking) for 10 minutes. The cells were then rinsed with PBS 3 times, for 5
minutes per rinse, and stored in dH2O until ready to image. Cells were never stored for longer than
24 hours at 4°C after preparation. For imaging, dH2O was replaced with a STORM Imaging Buffer
containing MEA, as described in the manufacturer’s protocol (Nikon N-STORM - GLOX + MEA
Imaging Buffer) immediately before imaging, and replaced every two hours to maintain quality of
imaging. Images were acquired with the Nikon NIS-Elements software and Nikon Eclipse Ti2-E
microscope, using an Apo-Plan TIRF 100X 1.49 NA objective and STORM 3D lenses. Laser lines
488nm and 647 were used for excitation of the sample and emission was collected with a Quad
C161417 TIRF filter set with band pass emitters at 525/50nm, 600/50nm and 700/72nm with a
collection time of 5000 periods.

Neuronal Morphological Analysis:
All neurons used in this study were subjected to several measurements of their morphological
characteristics. All images were captured as z-series with a Nikon T2i Inverted Confocal Microscope,
as described above. Prior to analysis, NIH ImageJ was used to create a two-dimensional,
background-subtracted maximum projection image from the confocal Z-series images for each
neuron. Dendrite number was measured by quantifying the number of dendrite tips per neuron.
Tips of any protrusion shorter than 5μm were excluded. Dendritic length measurements were made
by tracing from the cell body to the dendrite tip in ImageJ. For Sholl analysis, maximum projection
images were converted to binary and subjected to analysis in ImageJ. In the Sholl Analysis plugin, a
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step size of 5μm was set, with a starting point in the center of the soma. Concentric rings radiating
from the center point, at the set step size, were used to quantify dendrite morphology as it relates
to distance from the soma.

Statistical Analysis:
Data was analyzed using GraphPad Prism. Statistical significance for Sholl data was determined using
a Two-way ANOVA with Bonferroni post-hoc analysis. For all other comparisons, significance was
determined using the Student’s t test, using a two-tailed test which assumes unequal variances.
Significance was assigned at p < 0.05.
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